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INTRODUCTION
        Hemiplegia  secondary to vascular disorders occurs in children 
with an incidence of about  1  – 3 cases per 1,00,000 per year. The pediatric 
causes of stroke are distinctive compared with adult causes.  The causes of 
stroke in children are far different from the usual causes in adults.  Children 
have not had the time to develop hardening of the arteries (atherosclerosis) or 
other  long-term  effects  of  hypertension,  high  cholesterol,  diabetes,  and 
smoking that are among the most common stroke risks in adults.
        As with adults, the functional deficits caused by the stroke depend 
on its size and the specific areas of the brain affected. Paralysis of affected 
limbs and subsequent development of spasticity in those limbs can occur if 
motor areas are affected. Balance mechanisms are impaired if the cerebellum 
or  its  related  structures  are  involved.  Language  deficits  (aphasia)  occur  if 
language areas are involved. The list is as long as that for adults. Children, 
however, have more "plasticity" in their brains, meaning . This means that the 
areas of the brain have not yet been "locked" into their lifelong function. Thus 
other areas of the brain can take over the function of destroyed parts to a 
somewhat greater degree than in adults. The result is that children with stroke 
tend to have a greater degree of recovery in the long term than adults do. The 
younger the child at the time of stroke, the greater is this tendency. arterial 
thrombosis,  In children the relative rarity of the condition   contributes to  the 
reluctance in to considering  the diagnosis.
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ARTERIAL SUPNEUROANATOMY
PLY OF THE BRAIN
Characteristics of the Cerebral Arteries
The CIRCLE OF WILLIS 
         It is is a confluence (actually a hexagon) of vessels that gives rise 
to  all  of  the  major  cerebral  arteries.  It  is  fed by the paired internal  carotid 
arteries  and  the  basilar  artery.  When  the  circle  is  complete,  it  contains  a 
posterior communicating artery on each side and an anterior communicating 
artery. Despite these variations, occlusion of each of the major cerebral arteries 
usually produces a characteristic clinical picture.
The arteries course in the subarachnoid space, often for a considerable distance, 
before entering the brain itself; rupture of an aneurysm of of a vessel (eg, from 
an aneurysm that has burst) tends to cause a subarachnoid hemorrhage.
Each  major  artery  supplies  a  certain  territory,  separated  by border 
zones (watershed areas) from other territories; sudden occlusion in a vessel 
affects its territory immediately, sometimes irreversibly.
PRINCIPAL ARTERIES
       The arterial blood for the brain enters the cranial cavity by way of 
two pairs of large
 vessels): the internal carotid arteries, which branch off the common 
carotids, and the vertebral arteries, which arise from the subclavian arteries. 
The  vertebral  arterial  system supplies  the  brain  stem,  cerebellum,  occipital 
lobe, and parts of the thalamus, and the carotids normally supply the remainder 
of  the  forebrain .(Fig.  1). The  carotids  are  interconnected  via  the anterior 
cerebral  arteries and  the anterior  communicating  artery; the  carotids  are 
also connected to the posterior cerebral arteries of the vertebral system by 
way of two posterior communicating arteries, part of the circle of Willis
Abbreviations
bbr
Name of Artery Distribution
ACA Anterior  Cerebral 
Artery
Supplies most medial portions of frontal lobes 
and superior medial parietal lobes
AComA Anterior 
Communicating 
Artery
Connects the anterior cerebral arteries at their 
closest juncture
ICA Internal  Carotid 
Artery
Ascends through base of skull  to give rise to 
the  anterior  and middle  cerebral  arteries,  and 
connect with posterior half of circle of Willis 
via posterior communicating artery
MCA Middle  Cerebral 
Artery
Trifurcates into temporal,  frontal,  and parietal 
branches that supply most of the parenchyma 
of these lobes
PComA Posterior 
Communicating 
Artery
Connects the anterior circle of Willis with the 
posterior  cerebral  artery  of  vertebral-basilar 
circulation posteriorly
PCA Posterior  Cerebral 
Artery
Supplies  the  occipital  lobe  and  the  inferior 
portion of temporal lobe. A branch supplies the 
choroid plexus.
SCA Superior 
Cerebellar Artery
Supplies  the  dorsal  cerebellum,  pons,  and 
midbrain
BA Basilar Artery Formed  by the  junction  of  the  two  vertebral 
arteries, it terminates as a bifurcation into the 
posterior cerebral arteries
AICA Anterior  Inferior 
Cerebellar Artery
Supplies  the  inferior  cerebellum and portions 
of pons and medulla
VA Vertebral Artery The vertebrals emerge from the posterior base 
of skull and merge to form the basilar artery
PICA Posterior  Inferior Supplies  the  inferior-posterior  cerebellum, 
Abbreviations
bbr
Name of Artery Distribution
Cerebellar Artery choroid plexus in 4th ventricle, and portions of 
medulla
ASA Anterior  Spinal 
Artery
Descends along the anterior (ventral) aspect of 
the spinal cord


MOTOR HOMUNCULUS 
      A figurative representation of the body map encoded in primary 
motor cortex. Body parts with complex repertories of fine movement, like the 
hand,  require  more  cortical  space  in  M1,  while  body  parts  with  relatively 
simpler movements, like the hip, require less cortical space. (Fig. 2).
                  
PATHOPHYSIOLOGY 
-size//// //  100g/min  Cerebral Perfusion Pressure  
         Cerebral perfusion pressure (CPP) is defined as the difference between 
mean arterial and intracranial pressures. Normal cerebral perfusion pressure is 
80 mmHg, but when reduced to less than 50 mmHg there is metabolic evidence 
of  ischemia  and  reduced  electrical  activity.  Mean  arterial  pressure  is  the 
diastolic pressure plus one third of the pulse pressure (difference between the 
systolic and diastolic).                                                                      
CPP = MAP – ICP
         Cerebral blood flow is maintained at a constant level, ranging 
from 20ml/100g/ min   in white matter to 70ml/100g/min   in grey matter,   in the  
face  of  the  usual  fluctuations  in  blood  pressure  by  the  process  of 
autoregulation.  Autoregulation maintains  a  constant  blood  flow  between 
MAP  50 mmHg  and  150 mmHg.  However  in  traumatisedtraumatized or 
ischaemicischemic brain, CBF may become blood pressure dependent. Thus as 
arterial pressure rises so CBF will rise causing an increase in cerebral volume. 
Similarly, as  pressure  falls, so  CBF  will  also  fall,  reducing  ICP,  but  also 
inducing an uncontrolled reduction in CBF. In this situation if CPP falls below 
the  critical  value  of  70 mmHg,  the  patient  will  have  inadequate  cerebral 
perfusion. Autoregulation will cause cerebral vasodilatation leading to a rise in 
brain volume. This in turn will lead to a further rise in ICP and induce the 
vicious circle described by the vasodilatation cascade (Fig 3a) which results in 
cerebral ischaemia. This process can only be broken by increasing the blood 
pressure to raise CPP, inducing the vasoconstriction cascade (Fig 3b). Carbon 
dioxide causes  cerebral  vasodilation,  whereas  Oxygen. :causes  cerebral 
vasoconstriction.
ISCHEMIC PENUMBRA 
       Core is the central area where ischemia is severe & infarction 
develops rapidly with a blood supply of 0 – 12 mL/100 g/min.
       Penumbra(fig 6) is the marginally perfused area surrounding the 
core which has the capacity to recover should perfusion be restored 
promptly with a blood supply of 20- – 50  mL/ 100 g/ min. 
       Complete interruption of cerebral blood flow results in
 Suppression of electrical activity within 12– 15 sec  
 Inhibition of transsynaptic excitation after 2- 4 min  
 Inhibition of electrical excitability after 4- 6 min  
 Breakdown of metabolism shortly thereafter  
       Neurons and glia remain alive but functionless for as long as 
30 min before cellular death occurs. The possibility that restoration of 
flow during the interval between loss of neuron activity and tissue death 
might restore function is the basis for therapy of the evolving cerebral 
infarction (Fig. 4)..
DEFINITION ANSD CAUSES OF HEMIPLEGIA:
DEFINITION 
        Hemiplegia is defined ais a condition involving total paralysis or 
partial paralysis of one side of the body. 
MOTOR HOMUNCULUS 
A figurative representation of the body map encoded in primary motor cortex. 
Body parts with complex repertories of fine movement, like the hand, require 
more  cortical  space  in  M1,  while  body  parts  with  relatively  simpler 
movements, like the hip, require less cortical space.
CAUSES OF HEMIPLEGIA
        The differential diagnosis of acute hemiplegia includes more than 
stroke. At least three other disorders need to be considered in children. 
 Transient postictal hemiparesis (Todd paralysis) lasts less than 24 hours,   
usually has epileptiform activity on EEG , and never has acute infarction 
on MR imaging. 
 Complicated  migraine  is  usually  preceded  by  severe  headache;  focal   
deficits usually last hours, rarely up to a week; often there is a family 
history  of  migraine or specifically  hemiplegic  migraine ;  and MR or 
neuroimaging studies are normal. 
 Alternating hemiplegia is a rare disorder of unknown etiology. It usually   
begins  in  children  younger than 2 years;  episodes  of  hemiplegia  last 
minutes to  hours,  rarely longer  than a day;  weakness varies between 
sides;  seizures are common but usually do not occur during episodic 
weakness;  and most  children  have  a  progressive  neurodevelopmental 
deterioration.
STROKE
       A clinical syndrome typified by rapidly developing signs of focal or 
global disturbance of cerebral functions, lasting more than 24 hours or leading 
to death, with no apparent causes other than of vascular origin.
Stroke is defined as the sudden occlusion or rupture of cerebral arteries or veins 
resulting in focal cerebral damage and clinical neurologic deficits that persist 
for longer than 24 hours. 
 TYPES OF STROKES: 
                  Stroke can be ischemic, hemorrhagic, or both. 
Ischemic stroke can be either arterial or venous.
Arterial  strokes  usually  result  from  thromboembolic  occlusion  of  cerebral 
arteries. 
Venous strokes result from thrombosis in cerebral veins and sinuses.
       Hemorrhagic  stroke can  occur  from bleeding  into  an  acute 
ischemic stroke or from rupture of intracranial arteries.
• In children, ischemic stroke is more common than hemorrhagic 
stroke.  
TIMING OF STROKES 
• Before 28 days of age: 
o Perinatal  stroke encompasses  cerebrovascular  events 
that occur  from  between the  28 weeks of gestation  and  to  one 
month following birth. 
o A stroke that occurs before birth may also be called an in-
utero stroke or fetal  stroke.  Another term often used in this 
group is prenatal stroke. Stroke occurs more  frequently in the 
perinatal and prenatal age group than in older children.
• Childhood stroke occurs between 1 month and 18 years of age. 
INCIDENCE OF STROKE
       Arterial ischemic stroke around the time of birth is recognized 
in one in 4000 full -term infants (2).  
Arterial ischemic stroke which occurs in childhood ranges from 0.6 to 
7.9 per 100,000 children (1). 
Approximately 75% are arterial and 25% sinovenous thrombosis. 
The incidence of hemorrhagic stroke in children is estimated at 1.5 to 
5.1 per 100,000 children per year.
CLINICAL PRESENTATION 
         The most common clinical presentation of clinical stroke in 
childhood is acute hemiparesis.  
Headache and vomiting are common in children with  hemorrhagic stroke and  
Headache  and  decreased  level  of  consciousness  in  children  with  cerebral 
venous  thrombosis. Seizures,  facial  palsy  and  aphasia  can  be  associated 
features depending on the area involved.
MEITIOLOGYAJOR  CAUSES OF  ISCHEMIC  STROKE  IN 
CHILDREN 
Cardiac (25-50%)
Congenital heart disease -—
 VSD, ASD, PDA,  Ttetralogy of Fallot, aortic stenosis, coarctation of 
the aorta , VSD, ASD, PDA 
Acquired heart disease -—
Rrheumatic fever, prosthetic valve, endocarditis, cardiomyopathy, atrial 
myxoma,
 rhabdomyoma
Cardiac surgery
Hematologic
Prothrombotic state (35%)
     abnormal  activatedActivated protein C resistance (factor V 
Leiden); 
deficiencies of proteinProtein C, protein S and , antithrombin III 
deficiencies, 
                    antithrombin III; 
Pprothrombin gene mutation; 
Aantiphospholipid antibodiess;
Llupus anticoagulant
Sickle-cell anemia (10%)
Disseminated Iintravascular Ccoagulation
Leukemia, hemophilia, thrombocytopenia, polycythemia
Traumatic
Arterial dissection (10-25%)
Intraoral trauma
Fat or air embolism
Vascular
Moyamoya syndrome (25%)
Fibromuscular dysplasia
Migraine
Vasculitis
Meningitis - —bacterial, viral, TB, fungal, parameningeal
Varicella
Systemic Llupus Eerythematosus
Takayasu arteritis
Kawasaki disease
Inflammatory bowel disease
Drug abuse - —cocaine, amphetamine
Metabolic
Organic acidurias
Homocystinuria
Propionic, methylmalonic, isovaleric aciduria
Glutaric aciduria (I, II)
Mitochondrial
Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like 
episodes  (MELAS)
 Leigh syndrome - —pyruvate dehydrogenase complex defects
 Cytochrome oxidase deficiency
Lysosomal
Fabry disease
Cystinosis
Urea cycle defects
Partial ornithine transcarbamylase deficiency
Carbamyl phosphate synthetase deficiency
Other metabolic causes
Molybdenum cofactor deficiency
Sulfite oxidase deficiency
     Familial hyperlipidemia
   Toxic
Cocaine,
 Methamphetamine,
 Phencyclidine
          The reported incidence varies between different centers, possibly reflecting 
differences in referral patterns, populations studied, and investigator expertise. 
Many children have multiple risk factors.
STROKE IN SICKLE CELL DISEASE (SCD)
Age years
Incidence,  number
of  strokes  per  100
patient years Prevalence, %
<2 0.13 2.29
2-5 1.02 4.93
6-9 0.79 5.52
10-19 0.41 5.33
ETIOLOGY OF HEMORRHAGIC STROKE 
Trauma
Shaken impact syndrome
Head trauma - —closed, penetrating, vaginal delivery
Coagulopathy
     Hemophilia
     Thrombocytopenia - —idiopathic, thrombotic, hemolytic-uremic 
syndrome
     Liver disease
     Neonatal vitamin K deficiency
     Anticoagulants - —warfarin, heparin
Vascular anomalies
     Arteriovenous malformation
     Cavernous malformation
     Aneurysm - —congenital, traumatic, coarctation of the aorta
Sickle-cell disease
Others
     Hypertension
     Drug abuse - —cocaine, amphetamine
     Hemorrhagic transformation of ischemic infarction
 GUIDELINE FOR MANAGEMENT:
         There are no published consensus  guidelines on the 
evaluation of stroke in children, but several systematic approaches have 
been recommended. The evaluation should include:
• Questions about any history of head trauma, neck trauma, recent   
infection,  illness,  unexplained  fever  or  malaise,  drug  ingestion, 
developmental  delay,  family  history  of  bleeding  problems,  and 
associated headache.
• Careful family history, with special attention to premature vascular   
disease, hematologic disease, mental retardation.
• Physical  exam  including  head  circumference  in  children,  skin   
abnormalities, cardiac evaluation and carotid artery examination.
• MRI and MRA (CT if MR unavailable).  
If  the  MRI  and  MRA  reveal  an  infarct,  with  vascular 
distribution, then consider the following diagnostic tests:
1. Echocardiogram, EKG  
2. Blood studies including CBC, Protein S, Protein C, Antithrombin   
III, homocysteine, lipid profile, antiphospholipid antibody, infection 
screen
3. Tuberculosis screening  
4. Lumbar puncture  
5. Transcranial Doppler  
If  the  MRI  and  MRA  reveal  an  infarct,  with  non-vascular 
distribution, then consider the following diagnostic tests:
• Plasma Lactate and pyruvate  
If  the MRI and MRA reveal a hemorrhage,  then consider the 
following diagnostic tests:
• Coagulation studies  
If the MRA is normal, then consider the following diagnostic 
tests:
• Conventional Angiography  
General Diagnostic Evaluation
         The general approach to diagnostic evaluation should be question - and 
hypothesis-driven:
1.       Is there a cerebrovascular lesion? Several disorders can mimic a stroke. 
Transient  neurologic  deficits  can  be  seen  after  a  seizure,  with 
hypoglycemia or complicated migraine.
2.       Is  there  a  cerebral  infarction or  hemorrhage? This  is  crucial  because 
etiology and treatment are different between these two processes.
3.       What is  the cause of the stroke? Congenital  heart  disease, sickle-cell 
disease,  and  prothrombotic  disorders  are  common.  No  cause  can  be 
found in about one-third of patients.
       Initial evaluation includes a CBC with platelet count, electrolytes 
and glucose, PT/PTT, toxicology screen, chest x-ray, and ECG.
       Computed cranial tomography (CT) without contrast, is usually 
the first imaging test used because it is easy to perform and readily available.  
The head CT can distinguish between hemorrhage and ischemic infarction but 
is often normal in the first hours of infarction sometimes up to 24 hours. A 
subtle effacement of sulci may be the first clue to infarction. 
       Magnetic resonance imaging is more sensitive than CT for early 
detection of infarction, but it may be normal in the first few hours. 
       Diffusion-weighted  imaging is  good  for  early  detection  of 
infarction and if positive can help date the stroke. 
       Magnetic resonance angiography is a good method to detect 
changes in blood flow in the large intracranial and cervical vessels but less 
reliable with small vessels. 
       Magnetic  resonance venography is  the  investigation  of  choice  for 
cerebral venous thrombosis.
        Once the diagnosis  of stroke is established, a comprehensive 
workup must be performed. Transesophageal echocardiography (TEE) may 
be  more  accurate  than  transthoracic  echocardiography  (TTE)  to  detect 
structural abnormalities of the heart. Bubble contrast should be used to detect 
right-left  shunt.  Because embolism is  the  most  frequent  cause of  childhood 
stroke, a careful cardiac examination is essential.
        Lumbar puncture (LP), for cerebrospinal fluid examination, should be 
done  if  infection,  inflammation,  or  subarachnoid  hemorrhage  (SAH)  is 
suspected.  This  procedure  should  not  be  performed  if  there  is  clinical  or 
neuroradiologic evidence for increased intracranial pressure. LP in a patient 
with a unilateral hemispheric or cerebellar lesion may lead to transtentorial or 
transmagnal herniation. Small SAH may be evident in the cerebrospinal fluid 
but not on head CT.
        Transcranial  Doppler (TCD) is  a  noninvasive and portable 
method used for imaging the circle of Willis and the vertebrobasilar system. 
TCD is useful in predicting stroke in children with sickle cell disease, and can 
detect vasospasm in SAH.
       Evidence  for  prothrombotic  state,  coagulopathy,  systemic 
infection  or  inflammation should  be carefully  investigated.  Approximately 
30% of children with ischemic stroke have abnormalities in their prothrombotic 
factors.  Lactate  and  pyruvate  levels  should  be  obtained  if  mitochondrial 
disorder is suspected. CSF lactate and pyruvate values may be necessary to 
make  the  diagnosis,  even  though  serum  levels  are  normal.  Hemoglobin 
electrophoresis;  VDRL, HIV,  and varicalla  titers;  and PPD should  be done 
when clinically indicated.
         The diagnostic evaluation should not stop if one risk factor is 
identified, because pediatric stroke patients can have more than one cause for 
their cerebrovascular event. 
        Conventional  angiography should  be  reserved  for  patients  with 
nontraumatic intracranial hemorrhage or when vasculitis is suspected, if other 
imaging  modalities  have  been  normal.  Small  aneurysms,  arteriovenous 
malformation, or cavernous malformations may not show up on MR imaging or 
MR angiography. The angiography may not detect vascular malformations if 
they are surrounded by hematoma and edema. Repeating the angiography or 
waiting until the hematoma has resolved may be necessary in this case.
        If there is no evidence for infarction or intracranial hemorrhage, 
other  conditions  that mimic stroke such as transient postictal  hemiparesis, 
migraine, hypoglycemia, and alternating hemiplegia must be excluded 
Summary of information provided at the CHASA medical conference, 
2002.
Algorithm showing the evaluation of stroke in the pediatric patient.
    Algorithm showing the evaluation of stroke in the pediatric patient. 
CAUSES OF ISCHEMIC STROKE IN A CHILD
Risk factors for acute stroke are present in 80% of children. Even children with 
an obvious cause for their stroke should have a detailed workup for other 
associated factors.
Varicella within 9 months of the infarction suggests possible varicella 
vasculopathy. Oral contraceptives, amphetamines, and cocaine predispose to 
infarction. A family history of early-onset stroke or heart disease, pulmonary 
embolism, or deep vein thrombosis increases the risk of an inherited 
prothrombotic disorder.
The differential diagnosis of acute hemiplegia includes more than stroke. At 
least three other disorders need to be considered in children. 
• Transient postictal hemiparesis (Todd paralysis) lasts less than 24 
hours, usually has epileptiform activity on EEG, and never has acute infarction 
on MR imaging. 
• Complicated migraine is usually preceded by severe headache; 
focal deficits usually last hours, rarely up to a week; often there is a family 
history of migraine or specifically hemiplegic migraine; and MR or 
neuroimaging studies are normal. 
Alternating hemiplegia is a rare disorder of unknown etiology. It usually begins 
in children younger than 2 years; episodes of hemiplegia last minutes to hours, 
rarely longer than a day; weakness varies between sides; seizures are common 
but usually do not occur during episodic weakness; and most children have a 
progressive neurodevelopmental deterioration.
IDIOPATHIC: one-third of cases 
CARDIAC DISORDERS OR HEART DISEASES 
Complications of congenital heart disease cause more than 25% of the 
identifiable causes of pediatric stroke. Most of these are caused by emboli that 
arise in the heart or are shunted through the heart. Emboli should be suspected 
whenever there are multiple infarctions.
Emboli can be infectious or noninfectious. 
• Septic emboli from bacterial endocarditis can cause stroke from infarction 
or rupture of mycotic aneurysms. 
• Noninfectious emboli can be cardiogenic or systemic. 
Emboli formed on the left side of the heart have direct access to the cerebral 
circulation. 
Thrombus can form in the apex of poorly contracting ventricles. 
Marantic endocarditis occurs in children with malignancies or coagulopathies. 
Many emboli arise from prosthetic cardiac valves. 
Cardiac rhabdomyoma in children with tuberous sclerosis can be a source of 
emboli.
Systemic venous emboli can reach the cerebral circulation if an atrial or 
ventricular septal defect permits intracardiac right-to-left shunting. Patent 
foramen ovale is a common finding on echocardiography. These are usually 
innocent, but on occasion emboli can pass through them and cause stroke. 
Systemic emboli can arise from venous clots in children with prothrombotic 
disorders. 
Air emboli can occur during cardiac surgery. 
Fat emboli can arise from long-bone fractures.
Up to 50% of strokes in children with congenital heart disease occur within 3 
days of catheterization or surgery. The exact incidence of stroke is unknown 
and depends on numerous variables, including the surgical procedure 
performed. Recent studies report strokes in up to 8.8% of children following 
Fontan surgery. There is a 5% risk of stroke during valve replacement surgery 
when children are not anticoagulated. With anticoagulation, the risk is much 
lower.
Children with cyanotic heart disease and polycythemia are at risk for 
thrombotic stroke when decreased cardiac output lowers cerebral blood flow. 
This is most common in children younger than 2 years. Strokes occur in up to 
4% of children with tetralogy of Fallot or transposition of the great arteries.
BLOOD DISORDERS are the second most common cause of stroke 
in children.  Several blood disorders associated with stroke in 
children include:
     Coagulation disorders:
Thrombophilia means an increased tendency for the blood to clot.  
There are several reasons why the blood by have this increased 
tendency to clot and these include problems with proteins in the blood. 
Proteins are needed to help the blood clot.  If a protein has an odd 
shape or there isn't enough or there's too much of a it, then there may 
be problems with clotting.  Sometimes inherited conditions from one or 
both parents may cause problems with these clotting 
proteins. Sometimes a genetic mutation can cause thrombophilia.  A 
person who has inherited thrombophilia is at increased risk of 
developing a blood clot and this blood clot can cause a stroke.
Inherited causes of thrombophilia include:  deficiencies of 
antithrombin, protein C and protein S; elevated Factor VIII; Factor V 
Leiden (activated protein C resistance); Factor II 20210A; and 
dysfibrinogenemia.  Most of these are autosomal dominantly inherited.  
Hyperhomocysteinemia may be inherited or acquired and non-inherited 
factors influence Factor VIII levels.
Tests for Hypercoagulable State:  CBC, PT, PTT, Proteins C and S, 
Antithrombin, Factor V Leiden (and/or APC resistance), Factor VIII C, 
Factor II 20210 A, Fasting homocysteine, Lupus Anticoagulant, and 
anticardiolipin antibody.
Ischemic stroke can be caused by either inherited or acquired coagulation 
disorders. Approximately 30% of children with ischemic infarction have one or 
more abnormalities in prothrombotic factors, most frequently an anticardiolipin 
antibody. Stroke usually occurs in the setting of a systemic illness, other acute 
problem, or second risk factor that temporarily increases the risk of thrombosis.
The inherited coagulation disorders include activated protein C resistance 
(factor V Leiden); deficiencies of protein C, protein S, or antithrombin; 
prothrombin gene mutation; and hyperhomocysteinemia. Activated protein C 
resistance is a very common cause of venous thrombosis but rarely causes 
arterial thrombosis in older children and adults. The risk of thrombosis is 
increased in patients who smoke or use oral contraceptives. Activated protein C 
resistance is usually caused by a mutation in factor V, and this has been 
reported as a cause of neonatal stroke and hemiplegic cerebral palsy.
Deficiencies of protein C, protein S, or antithrombin occur much less 
frequently than activated protein C resistance. Over 250 gene mutations cause 
these disorders. Some of these reduce protein production; others alter protein 
function. Because of this, functional assays of protein C, protein S, or 
antithrombin are the most effective way to screen for these disorders. Any of 
these disorders can cause ischemic stroke in children. Neonates with 
homozygous mutations can have purpura fulminans or disseminated 
intravascular coagulation. Acquired deficiencies can result from vitamin K 
deficiency, oral anticoagulants, oral contraceptives, nephrotic syndrome, liver 
disease, recent thrombosis, surgery, or disseminated intravascular coagulation.
Acquired coagulation disorders are much more common. In a prospective study 
of 92 children with cerebral thromboembolism, 38% of the children had a 
prothrombotic disorder. The vast majority of these were antiphospholipid 
antibodies, either anticardiolipin antibody or lupus anticoagulant. Many 
patients had multiple abnormal prothrombotic factors, suggesting an acquired 
process. The abnormalities may persist for months or may fluctuate.
The antiphospholipid antibody syndrome is characterized by a positive 
antiphospholipid antibody and recurrent thrombotic events. The disorder is 
primary if there is no systemic disease and secondary if the child has systemic 
lupus erythematosus. Antiphospholipid antibody syndromes are rare causes of 
pediatric stroke. When they occur, they need to be treated with oral 
anticoagulants or low-molecular-weight heparin.
 Among several factors involved in the origin of pediatric stroke, the role of an 
inherited promthrombotic state is currently under investigation.  Some 
researchers suggest that a detailed search for mutations in inherited 
thrombophilia is necessary in all cases of pediatric stroke.
Definitions
Anticardiolipin Antibodies
Antiphospholipid syndrome (APS): currently recognized as a 
common risk factor for arterial or venous thromboembolic disease. 
Factor V Leiden is an inherited disorder that can lead to abnormal 
blood clotting (coagulation) or thrombophilia.  The Factor V Leiden is 
the most common hereditary blood coagulation disorder in the United 
States.  The name Factor V Leiden means that there's a mutation in the 
DNA in the gene used to make the Factor V protein.
Hyperhomocysteinaemia: elevated homocysteine plasma levels have 
been found in children with stroke 
Methylenetetrahydrofolate Reductase Mutation (MTHFR): One of 
the most common genetic defects of homocysteine metabolism is a 
mutation in the enzyme MTHFR.  Increased plasma homocysteine is a 
risk factor for arteriosclerotic vascular disease and deep-vein 
thrombosis. 
Plasminogen deficiency: an uncommon cause of inherited thrombosis.
Protein C and Protein S:  involved in regulation of coagulation (blood 
clotting); they inactivate factors V and VIII.
Protein C deficiency:  can result in excessive clotting. These clots tend 
to form in veins, not arteries.  This disorder can be either inherited or 
acquired
Protein S deficiency:  can result in excessive clotting tendencies.  
These are usually vein clots, such as deep vein thrombosis, but 
occasionally this disorder can be associated with arterial clots
Prothrombin Gene mutation 020210:  an inherited mutation that can 
result in blood clots. A mutation in the prothrombin gene makes the 
body produce too much of the prothrombin protein, resulting in an 
increased tendency for the blood to clot.
Sickle cell anemia 
Approximately 10% of pediatric strokes occur in children with sickle-cell 
disease (SCD). Children with SCD can have TIAs, ischemic stroke, 
hemorrhagic stroke, or any combination of these. As a rule, ischemic stroke 
occurs most frequently in infants and young children, and hemorrhagic stroke 
occurs in adults. The incidence of stroke is highest in children with the SS 
genotype, but other common genotypes (SC, S-β+, S-β°) also have an increased 
risk.
The risk of stroke varies widely in different reports. The results of the 
Cooperative Study of Sickle Cell Disease are summarized in Table 25-14. 
Stroke rarely occurs in children younger than 2 years. Children between 2 and 
5 years have the highest incidence. The overall prevalence in children younger 
than 20 years was 5.5%.
Factors that increase the risk of ischemic stroke include prior transient ischemic 
attacks (TIAs), low hemoglobin concentration, acute chest syndrome, and 
increased blood pressure. Children with SCD and α-thalassemia have a lower 
risk of stroke, possibly because they have a higher hemoglobin concentration. 
Although a high concentration of hemoglobin F decreases the risk of other 
complications of SCD, it does not lower the risk of stroke.
As many as 17% of children with SCD have radiographic evidence of stroke 
but do not have a history of stroke or TIA. "Silent infarctions" may cause lower 
IQ scores in children without obvious neurologic disease. Children with silent 
infarctions have an increased risk of symptomatic stroke and require very close 
surveillance.
Most ischemic strokes result from occlusion of large cerebral vessels, but small 
vessels can also be involved. Strokes often occur during a sickle-cell crisis. If 
narcotic analgesics are used for a painful crisis, the symptoms of stroke may be 
difficult to interpret. Most children present with hemiparesis, but aphasia, 
ataxia, visual disturbances, and seizures can also occur. Neurologic recovery 
depends on the size and location of the stroke. Most children regain motor 
function, but language deficits may persist. Ischemic stroke is rarely fatal, but 
there is a 26% mortality rate after hemorrhagic stroke.
Recurrent strokes are a major problem in children with SCD. Without 
treatment, 50 to 65% of children with one stroke will have a second. The vast 
majority of second strokes occur within 3 years of the first stroke.
Ischemic stroke is best visualized with MR imaging. Smaller lesions can be 
detected with MR than with CT imaging. In addition, stroke can be detected 
earlier with MR imaging, especially if diffusion-weighted sequences are 
obtained. Magnetic resonance angiography (MRA) may reveal an isolated 
abnormality but more commonly shows a widespread vasculopathy.
The incidence of recurrent stroke can be reduced significantly with chronic 
transfusions to maintain the hemoglobin S concentration below 20 to 30%. 
Children treated with frequent transfusions have a high incidence of 
alloimmunization and iron overload. Vascular abnormalities may improve with 
chronic transfusions. Strokes may recur when transfusions are stopped; 
therefore most centers continue transfusion therapy indefinitely.
Children at risk for first stroke can be detected with transcranial Doppler 
ultrasonography (TCD). Patients with mean blood flow velocity in the internal 
carotid or middle cerebral artery greater than 200 cm per second have a very 
high risk for stroke. TCD should be used to screen all children with SCD, and 
children with high velocities should be started on chronic transfusion therapy.
Who is at risk for stroke?
Someone with only one gene which causes SCD has sickle trait and is 
usually free of symptoms because the normal hemoglobin (Hb A) 
counteracts the sickle hemoglobin (Hb S). If both genes controlling 
hemoglobin formation are the sickle type, the person has homozygous 
SCD. In rare cases, a person may have one S-type gene but no other 
gene at all, referred to as sickle beta thalassemia disease. These two 
types of SCD can be associated with stroke.
Children with SCD are 200 to 400 times as likely to suffer a stroke, 
compared to children without SCD or congenital heart disease.
The Cooperative Study of Sickle Cell Disease (CSSCD), a large 
prospective study, confirmed that stroke is a constant threat after age 2, 
but the incidence is highest in the middle of a child's first 10 years of life. 
About 11% of all children with homozygous SCD will develop stroke by 
20 years of age.
Some characteristics of SCD are associated with an increased risk of 
stroke, and include low hemoglobin, elevated white blood cell count, 
frequency of acute chest syndrome, and history of transient ischemic 
attack
How many children with sickle cell disease have stroke in the 
United States?
Of the 2000 children with SCD born in the US each year, about 10% will 
develop stroke by adulthood. Perhaps as many as one in five will have 
abnormal areas on magnetic resonance imaging scans of the brain that 
suggest some stroke-like damage has occurred in the past.
What causes stroke in sickle cell disease? 
The most prominent manifestation results from large artery disease. 
Stroke in children with SCD is not well understood, but one theory is 
that stroke usually happens when major arteries of the brain are 
narrowed or blocked
Many patients with an infarction have abnormal cerebral blood vessels. In 
general, the vessels that feed the brain (carotids and vertebrobasilar) are normal 
in their cervical portions. Stenosis or occlusion, however, often affects the 
distal internal carotid (dICA) and middle cerebral arteries (MCA). In most 
cases the vertebrobasilar system, even if the cerebral cranial portion, remains 
relatively normal.
Injury to the endothelium over time, possibly relating to red blood cell 
adherence to the endothelium and circulating inflammatory factors and white 
cells, may cause narrowing of vessels. The narrowing can be shown on 
angiography, and when it is significant, can be detected by TCD. 
At least 20% of patients with no history of stroke, no symptoms, or readily 
evident signs of brain injury, will have an abnormal MRI usually showing 
small lesions in the white matter which are associated with decreased 
performance in neuropsychological testing. These silent strokes may also 
indicate an increased risk of clinically evident stroke damage. 
In other cases, the arterial disease may cause clots which go further upstream 
and block arteries, causing stroke. Small arteries in the brain may also be 
blocked by sickled red blood cells. Rarely, stroke may be caused by the rupture 
of a blood vessel, causing a brain hemorrhage.
In SCD, children are most likely to have infarctions, but may have 
hemorrhages, often with fatal consequences. Multiple strokes cause cumulative 
damage and can result in severe physical and mental impairment.
Children with SCD who present with acute stroke symptoms require urgent 
evaluation and are usually treated with hydration and exchange transfusion.
INFECTION leads to a hypercoagulable state and has been found to be 
a risk factor for cerebrovascular disease.  CNS infection and systemic 
infection are perinatal risk factors.
Meningitis and encephalitis were among the most common risk 
factors in children hospitalized with stroke in California between 1991 
and 2000.
Brain abscess, sepsis, HIV, infection with Mycoplasma 
pneumoniae, and parvovirus B19 infections have been associated 
with stroke in children.
VASCULAR DISORDERS - 23% of children with arterial ischemic 
stroke in one study
Central nervous system vasculitis: 
can lead to arterial thrombosis, cerebral venous thrombosis, or intracranial 
hemorrhage. Inflammation of the cerebral vessels produces stenosis or 
occlusion and is caused by a variety of conditions such as infections, 
autoimmune diseases, drug abuse, radiation, or idiopathic disorders.
The most common cause of CNS vasculitis is bacterial meningitis. Cerebral 
infarction is found in 12 to 27% of children with bacterial meningitis. These 
children are more prone to seizures, and their outcomes are poor. Risk factors 
include high CSF white cell count, hypoglycorrhachia, age below 12 months, 
and delayed treatment. Antibiotic treatment should be started as early as 
possible. Steroids before the first dose of antibiotics may reduce the risk of 
neurologic and audiologic impairment. CNS vasculitis is seen in most children 
with tuberculous meningitis, and cerebral infarction in the basal ganglia area is 
common. Septic embolism caused by bacterial endocarditis can cause CNS 
vasculitis and stroke.
Several cases of childhood stroke following chickenpox infection have recently 
been reported. These cases share similar features. They all occur in children 
younger than 10 years, the infarcts occur in the basal ganglia or internal 
capsule, and most occur within 9 months of the rash. Focal stenosis, occlusion, 
or segmental narrowing is seen in the proximal anterior and middle cerebral 
arteries. Two recent studies have confirmed this association. A retrospective 
study from London revealed that 17% of children with stroke had history of 
chickenpox within 6 months of the ictus. A French case-control study showed a 
significant statistical link between recent varicella and idiopathic arterial 
stroke. Two-thirds of children in the stroke group had varicella within 9 months 
prior to the stroke compared to 9% in the control group. CSF cell count, 
protein, and glucose are often normal, but intrathecal varicella-zoster 
antibodies have been identified in three children. Possible mechanisms of 
stroke after chickenpox are vasculitis, transient hypercoagulable state, or 
sympathetic stimulation. Stroke recurrence is rare, but transient ischemic 
attacks have been reported. Optimal treatment remains unclear. Steroids and 
heparin and antiplatelet agents have been used. Adults with herpes zoster 
ophthalmicus can suffer delayed ipsilateral cerebral infarction caused by 
cerebral angiitis.
The incidence of symptomatic cerebrovascular disease in children with AIDS is 
1.3% per year, but autopsy studies have shown a higher rate of some type of 
cerebrovascular lesion including arteriopathy.
AUTOIMMUNE DISORDERS can cause focal deficits as a result of cerebral 
venous thrombosis, arterial thrombosis, or intracerebral hemorrhage. 
Cerebrovascular disease is seen in about 6% of adults with lupus, but a 
pediatric study identified only 2 of 120 children with lupus with 
cerebrovascular occlusion. Some cases are caused by vasculitis, but other 
pathologic processes need to be considered. Antiphospholipid antibodies, 
infections, complications of treatment, Libman-Sacks endocarditis, and 
thrombotic thrombocytopenic pupura can all cause stroke in patients with 
lupus. Neurovascular and thromboembolic complications, including vasculitis, 
were seen in 3% of children with inflammatory bowel disease.
Takayasu arteritis is an inflammatory disease of unknown etiology involving 
the aorta and its branches. Young Asian females are most often affected, and 
stroke is seen in 5 to 10% of these patients. The mechanism of cerebral 
infarction in this disorder is embolic or thrombotic. Immunosuppressive 
therapy with steroids and azathioprine improves outcome. Cerebral infarction 
has also been reported in Kawasaki disease and polyarteritis nodosa. Few 
pediatric cases of isolated angiitis of CNS have been reported. Without 
immunosuppressive therapy this disease is fatal.
Recent illicit drug use is found in 12% of young adults with ischemic stroke. 
Cerebral vasculitis has been associated with cocaine abuse and overdose of diet 
pills.
Lastly, cerebral radiation necrosis is a delayed CNS injury caused by small-
vessel vasculitis. This is a progressive disorder that leads to death or disability. 
Treatment modalities include anticoagulation and hyperbaric oxygen.
      ARTERIOVENOUS MALFORMATIONS
Moyamoya Disease
Moyamoya disease (MD) is a chronic progressive occlusive cerebrovascular 
disease of unknown etiology with typical angiographic features including 
stenosis or occlusion of the bilateral distal internal carotid arteries or the 
adjacent anterior, middle, or posterior cerebral arteries. There is a secondary 
formation of abnormal collateral vascular network (moyamoya vessels) at the 
base of the brain. The stenosis is caused by fibrous intimal thickening and 
fragmentation of the internal elastic lamina. Angiographic and histologic 
studies demonstrate similar changes in extracranial vessels. Several systemic 
disorders such as sickle-cell disease, neurofibromatosis, trisomy 21, 
tuberculosis, pharyngitis, fibromuscular dysplasia, aortic coarctation, cranial 
trauma, and irradiation have been associated with moyamoya vessels. This is 
often classified as angiographic moyamoya or moyamoya syndrome, and the 
patients have similar clinical features to those of MD.
MD was once believed to be specific to the Japanese. Lately increasing number 
of cases have been reported in other parts of the world. Epidemiologic studies 
from Japan show annual incidence of 0.35 per 100,000, with female to male 
ratio of 1:8 and peak age 10 to 14 years. Family history was found in 10% of 
patients. MD is rare in other races but has been reported in all ethnic groups 
showing similar epidemiologic, clinical, and radiologic features to those of 
Japan.
Children present with recurrent and progressive cerebral ischemia, whereas 
adults are more likely to develop cerebral hemorrhage. Intellectual decline, 
seizures, movement disorders, and headaches are also noted.
Diagnosis of childhood MD can usually be made by MR imaging and MRA. 
Conventional cerebral angiography is performed if there is need for surgical 
intervention. EEG shows the re-build-up phenomenon, a delayed return to 
baseline pattern, in many children with MD. Transcranial Doppler patterns 
correlate well with the clinical progression of the disease and can be helpful in 
the management of patients with MD. Positron emission tomography (PET) 
and proton magnetic resonance spectroscopy (MRS) are useful methods to 
evaluate cerebral hemodynamics and metabolism in children with MD.
No curative treatment is known for MD. In the acute phase patients with 
ischemic or hemorrhagic stroke should receive symptomatic treatment. 
Hyperventilation caused by heavy crying should be avoided because the 
vasoconstriction can worsen symptoms. Treatment modalities include medical 
treatment with vasodilators or anticoagulants, surgery, or observation. There 
are no randomized trials comparing surgery and medical treatment. 
Revascularization surgery is often used for repeated ischemic episodes. The 
most common and successful procedure is encephalo-duro-arterio-synangiosis 
(EDAS). A branch of the superficial temporal artery is sutured into the dura 
over the affected hemisphere to promote formation of anastomoses with 
cortical arterial branches. EDAS and its modified versions decrease the 
frequency of ischemic attacks and prevent deterioration in mental capacity. The 
optimal treatment plan for hemorrhagic MD is controversial, but often 
emergency ventricular drainage and evacuation of hematoma are necessary.
Transient ischemic attacks occur frequently during the first 4 years and 
decrease thereafter. Neurologic deficits and intellectual deterioration increase 
with time. Permanent deficits or poor outcome is found in 45% of children with 
MD, and poor prognosis correlates with early age at onset and hypertension. 
Early indirect revascularization surgery in children with ischemic MD may 
prevent neurologic deficits and improves function.
ARTERIAL DISSECTION, 
Cervicocephalic arterial dissections are among the major causes of stroke in 
childhood and adolescence. Arterial dissections occur when blood penetrates 
into the arterial wall through an intimal tear. The intramural hematoma splits 
the media, extends along the artery, and leads to stenosis or occlusion. 
Dissections can be traumatic or spontaneous and often involve more than one 
vessel. Because the trauma is often trivial, underlying arteriopathy is often 
suspected but rarely demonstrated. Dissections affect the internal carotid 
arteries (ICA) more frequently than vertebral arteries (VA) and the extracranial 
arteries more often than the intracranial vessels. However, intracranial arterial 
dissections are relatively more common in children compared to adults.
Cervicocephalic arterial dissection was found in 20% of French children with 
arterial ischemic stroke and in 6% of cases in a British childhood and 
adolescent stroke population. Dissections leading to ischemic stroke are more 
common in young adults than children.
Neurologic manifestations are related to luminal narrowing by the dissection or 
from artery-to-artery embolism from the dissection site. Young patients with 
cervicocephalic arterial dissection present with focal cerebral ischemic 
symptoms often preceded by ipsilateral headache, neck, or eye pain. 
Ophthalmologic manifestation such as Horner syndrome and transient 
monocular blindness are more frequent in adults with ICA dissection.
Cervicocephalic arterial dissection should be considered in any child with 
stroke, especially when there is history of antecedent trauma to the neck, 
intraoral trauma, fibromuscular dysplasia, congenital heart disease, or in 
otherwise idiopathic cerebral or retinal infarction with or without hemicrania. 
Dissections of the ICA and VA are most accurately diagnosed by cerebral 
angiography. The angiographic features include the string sign, which is an 
elongated irregular narrowing of the arterial lumen, tapered occlusion, but 
rarely a double lumen. MR imaging is a sensitive test in the diagnosis of 
cervicocephalic arterial dissection, especially if thin T1-weighted sections are 
obtained in axial and coronal planes with the fat-suppression technique. MRA 
can show arterial stenosis, but intimal irregularities and small aneurysms can be 
missed. Duplex sonography is a noninvasive and simple test and, if combined 
with Doppler examination, is sensitive in the diagnosis of dissection.
There are no prospective randomized studies that have addressed the efficacy 
of treatments for cervicocephalic dissections. Most strokes associated with 
cervical artery dissection occur within 2 weeks and are presumed to be 
thromboembolic. Early anticoagulation prevents clinical deterioration in adults 
with ICA dissection and is recommended for a few months by most authors. 
Anticoagulation is not advised in dissections of the intracranial vessels because 
of risk of subarachnoid hemorrhage. The recurrence risk at 10 years for all age 
groups is 12%, higher for younger than older patients. According to Schievink's 
study on spontaneous dissections in childhood and adolescence, complete 
recovery or minimal deficit occurred in 90% of cervical artery dissections 
compared to 60% of intracranial artery dissection.
METABOLIC STROKE
INTRODUCTION
Metabolic problems are a rare cause of pediatric stroke. Homocystinuria and 
Fabry disease cause vascular occlusion; other metabolic disorders do not cause 
vascular insufficiency and are more properly termed strokelike episodes. As 
listed in Table 25-15, metabolic strokes can be caused by organic acidurias, 
mitochondrial abnormalities, lysosomal disorders, and urea cycle defects.
Homocystinuria arises from one of several enzymatic defects. In the classical 
autosomal-recessive form, deficient cystathionine beta-synthase prevents the 
catabolism of cystathionine to cysteine, causing increased urinary homocystine 
and methionine. Most children with this disorder have mental retardation, 
ectopia lentis, marfanoid appearance, recurrent thromboembolic events, and 
severe atherosclerosis. The latter problem is often fatal in untreated patients. 
Homocystinemia injures vascular endothelium, leading to thrombus formation. 
Strokes are secondary to arterial or venous thrombosis or arterial embolism. 
Treatment is dietary with pyridoxine supplementation and methionine 
restriction.
Less severe elevations in serum homocystine are a cause of stroke in young 
adults and possibly children. These patients may be heterozygotes or may have 
other enzymatic defects. In addition, nutritional deficiencies in folate, vitamin 
B12, and vitamin B6 may cause hyperhomocystinemia. Several diseases (chronic 
renal failure, hypothyroidism, pernicious anemia, leukemia) and drugs 
(methotrexate, phenytoin, theophylline, cigarette smoking) increase plasma 
homocystine concentration. Cardo and colleagues reported elevated plasma 
total homocystine levels in 36% of children with acute ischemic stroke. A case-
control study in Dutch children reported increases in 18% of the children with 
ischemic stroke. Homocystine levels were also increased in patients with 
sickle-cell disease and stroke. Total serum homocystine should be measured in 
every child with acute ischemic stroke. Some experts also suggest doing a 
methionine loading test in children with ischemic stroke of undetermined 
etiology and normal total homocystine.
Any mitochondrial encephalopathy can present with a strokelike episode or can 
have these as part of the clinical syndrome. MELAS usually presents with 
episodic headache and emesis lasting hours to days. Transient hemiparesis or 
hemianopsia often follows. It usually presents in children between 5 and 15 
years but can have onset in infancy. Most children have proximal muscle 
weakness and progressive neurologic deterioration. Strokes usually occur in the 
posterior cerebrum with relative sparing of white matter; they do not have a 
vascular distribution. Some children have calcifications in the basal ganglia. 
Increased CSF lactate supports the diagnosis, but muscle biopsy and molecular 
blood analysis are required for confirmation. Most patients have a defect in 
complex I, but multiple defects of respiratory chain enzymes have been 
reported. The most common mutation is in tRNA at mtDNA position 3243.
Fabry disease is a rare, sex-linked lysosomal disorder. A deficiency of α-
galactosidase causes accumulation of ceramidetrihexoside in vascular 
endothelium, leading to progressive arterial narrowing, ischemia, and 
infarction. Stroke usually occurs in adults but has been reported in hemizygous 
adolescents. Ischemia occurs first in hemispheric white matter or deep gray 
matter, areas supplied by long, thin end arteries. Other features of the disease 
include pain in the extremities, abdomen, and joints; renal failure; and 
hypertension. Renal transplantation improves biochemical function, but its 
effect on cerebrovascular disease is unknown.
ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY is a urea 
cycle defect that presents in infancy with hyperammonemia and rapidly 
progressive neurologic dysfunction. Females with partial OTC deficiency can 
present in adolescence with migraine, ischemic stroke, or hyperammonemia. 
Treatment is with a protein-restricted diet.
MOLYBDENUM COFACTOR DEFICIENCY is an even rarer disorder 
with combined deficiencies of sulfite oxidase, xanthine dehydrogenase, and 
aldehyde oxidase. Affected infants have acquired microcephaly, seizures, and 
hypotonia. Most die during infancy; survivors have severe mental retardation, 
choreoathetosis, and spasticity. Imaging studies reveal cystic lesions in the 
white matter and cortex. Isolated sulfite oxidase deficiency has similar clinical 
and radiographic features.
CAUSES OF HEMORRHAGIC STROKE IN A CHILD
Hemorrhagic Stroke
Hemorrhagic stroke in children is as common as ischemic stroke. Bleeding 
occurs after rupture of normal blood vessels in children with head trauma or 
coagulopathies and abnormal vessels in patients with vascular malformations 
or aneurysms. Bleeding is classified as either subarachnoid, ie, into the 
subarachnoid space around the brain, or intraparenchymal, ie, into the brain 
parenchyma. Many patients have both subarachnoid and intraparenchymal 
hemorrhage. The disorders causing hemorrhagic stroke are listed in Table 25-
16. The etiology of a hemorrhagic infarction can usually be identified. 
Treatment is often surgical.
• Intraparenchymal hemorrhage usually presents with headache, focal 
neurologic signs, seizures, and altered consciousness. Small hemorrhages may 
have very subtle clinical signs, but large bleeds usually cause coma. In 
neonates, seizures and signs of increased intracranial pressure are more 
common. Subarachnoid hemorrhage usually presents with the sudden onset 
(thunderclap) of the worst headache of the child's life, followed by signs of 
meningeal irritation and increased intracranial pressure.
Acute hemorrhage is easily identified with CT, but within a few days the blood 
becomes isodense with brain parenchyma. Retinal hemorrhages may be 
detected on funduscopic examination. Blood is occasionally present in the 
spinal fluid when it is not detected with CT.
• Head trauma is the most common cause of pediatric intracranial 
hemorrhage. Cerebral contusion can occur alone or in association with subdural 
or epidural hemorrhage. Intracranial bleeding is very common in the shaken 
baby syndrome. Traumatic aneurysms can result from closed or penetrating 
head injuries. On very rare occasions, carotid-cavernous fistulas develop after 
fracture of the skull base. Traumatic delivery is often associated with neonatal 
intracranial hemorrhage.
• Coagulopathies are the next most common cause of hemorrhage. In 
most cases, the underlying coagulopathy is known. Very rarely, intracranial 
hemorrhage is the initial presentation. The hemorrhage is usually secondary to 
trauma, but the trauma may be very slight.
• Vascular malformations are divided into arteriovenous malformations, 
cavernous malformations, venous angiomas and capillary telangiectasias. The 
latter are a rare cause of bleeding in neurocutaneous syndromes. Arteriovenous 
malformations (AVMs) are comprised of abnormal primitive arteries and veins 
with varying amounts of intervening gliotic tissue. The malformations do not 
have a capillary bed between the arteries and veins. Small AVMs typically 
present with focal seizures; large AVMs with seizures, headache, focal 
neurologic signs, and intracranial bruit. Intermittent, relatively mild headache 
may be caused by periodic bleeding or mass effect. Acute severe headache may 
be secondary to intraparenchymal hemorrhage in small or large AVMs. 
Ischemic infarction can result from spontaneous thrombosis or vascular steal. 
Vein of Galen malformations usually present in infancy with high-output 
congestive heart failure and failure to thrive or in early childhood with 
hydrocephalus. AVMs can be detected with contrast-enhanced CT, MR 
imaging, MR or conventional angiography. There is a 4% risk of hemorrhage 
from unruptured AVMs and a high risk for recurrent hemorrhage. About 10% 
of first hemorrhages are fatal. Embolization or surgical removal is usually 
required to treat AVMs. Occasionally the presenting hemorrhage successfully 
obliterates an AVM.
• Cavernous malformations are collections of thin-walled vessels with a 
single layer of endothelium, no smooth muscle or elastic tissue, and no 
intervening brain parenchyma. They can occur alone or in association with 
other vascular malformations. They present in children with seizures, focal 
neurologic signs, or hemorrhage. In contrast to AVMs, hemorrhage in 
cavernomas is rarely life threatening. Recurrent bleeding is common, especially 
when the cavernous malformation is in the brainstem. Cavernomas can be 
familial or nonfamilial. Multiple cavernomas are common in the autosomal-
dominant form, and they are more likely to bleed. Cavernous malformations 
are rarely visualized on angiography because of the small size of the vessels 
and their low flow. However, on T2-weighted MR imaging, they have a bright 
center with dark surrounding ring.
• Venous angiomas are composed entirely of venous structures. They are 
the most common vascular malformation. Most patients are asymptomatic, but 
they can present with seizures. Venous angiomas are easily identified with 
contrast-enhanced CT or MR imaging. Even when they cause seizures, they 
rarely require surgery. In fact, surgery can increase venous congestion and 
make neurologic symptoms worse.
• Saccular aneurysms are rarely symptomatic and less frequent than 
AVMs. They arise from an area of congenital weakness in the arteries. They 
can be associated with coarctation of the aorta, polycystic kidneys, Ehlers-
Danlos syndrome, and Marfan syndrome. Aneurysms in children usually arise 
from the internal carotid artery or anterior cerebral artery. Giant aneurysms 
greater than 10 cm in diameter can occur. Sometimes, headache, focal 
neurologic signs, or hydrocephalus are the first signs; but aneurysms usually 
present with acute subarachnoid hemorrhage, frequently with intraparenchymal 
or intraventricular extension. Subarachnoid hemorrhage can cause significant 
vasospasm and cerebral ischemia. Surgery is the treatment of choice. Prior to 
surgery, patients are treated with nimodipine (to prevent vasospasm), sedation, 
and anticonvulsants.
THE EVALUATION OF STROKE IN CHILDREN
summary of information provided at the CHASA medical conference, 
2002 by John K. Lynch, DO, NINDS.  There are no published 
consensus guidelines on the evaluation of stroke in children, but several 
systematic approaches have been recommended. The evaluation 
should include:
• Questions about any history of head trauma, neck trauma, recent 
infection, illness, unexplained fever or malaise, drug ingestion, 
developmental delay, family history of bleeding problems, and 
associated headache
• Careful family history, with special attention to premature vascular 
disease, hematologic disease, mental retardation
• Physical exam including head circumference in children, skin 
abnormalities, cardiac evaluation and carotid artery exam
MRI and MRA (CT if MR unavailable)
If the MRI and MRA reveal an infarct, with vascular distribution, 
then consider the following diagnostic tests:
6. Echocardiogram, EKG
7. Blood studies including CBC, Protein S, Protein C, Antithrombin 
III, homocysteine, lipid profile, antiphospholipid antibody, infection 
screen
8. Tuberculosis screening
9. Lumbar puncture
Transcranial Doppler 
If the MRI and MRA reveal an infarct , with non-vascular 
distribution, then then consider the following diagnostic tests:
Plasma Lactate and pyruvate
If the MRI and MRA reveal a hemorrhage, then then consider the 
following diagnostic tests:
Coagulation studies
If the MRA is normal, then consider the following diagnostic tests:
Conventional Angiography
25.8.11 General Diagnostic Evaluation
The general approach to diagnostic evaluation should be question- and 
hypothesis-driven:
1. Is there a cerebrovascular lesion? Several disorders can mimic a stroke. 
Transient neurologic deficits can be seen after a seizure, with hypoglycemia or 
complicated migraine.
2. Is there a cerebral infarction or hemorrhage? This is crucial because etiology 
and treatment are different between these two processes.
3. Is it anterior or posterior circulation stroke? The prognosis tends to be worse 
in posterior circulation stroke. These patients may need closer observation and 
precautions to minimize airway compromise.
4. What is the cause of the stroke? Congenital heart disease, sickle-cell disease, 
and prothrombotic disorders are common. No cause can be found in about one-
third of patients.
A suggested format for diagnostic workup is provided in Fig. 25-26. Our 
initial evaluation includes a CBC with platelet count, electrolytes and 
glucose, PT/PTT, toxicology screen, chest x-ray, and ECG.
Computed cranial tomography (CT), without contrast, is usually the first 
imaging test used because it is easy to perform and readily available. The head 
CT can distinguish between hemorrhage and ischemic infarction but is often 
normal in the first hours of infarction sometimes up to 24 hours. A subtle 
effacement of sulci may be the first clue to infarction. Magnetic resonance 
imaging is more sensitive than CT for early detection of infarction, but it may 
be normal in the first few hours. Diffusion-weighted imaging is good for early 
detection of infarction and if positive can help date the stroke. Magnetic 
resonance angiography is a good method to detect changes in blood flow in 
the large intracranial and cervical vessels but less reliable with small vessels. 
Magnetic resonance venography is the investigation of choice for cerebral 
venous thrombosis.
Once the diagnosis of stroke is established, a comprehensive workup must be 
performed. Because embolism is the most frequent cause of childhood stroke, a 
careful cardiac examination is essential
. Transesophageal echocardiography (TEE) may be more accurate than 
transthoracic echocardiography (TTE) to detect structural abnormalities of the 
heart. Bubble contrast should be used to detect right-left shunt.
Lumbar puncture (LP), for cerebrospinal fluid examination, should be done if 
infection, inflammation, or subarachnoid hemorrhage (SAH) is suspected. This 
procedure should not be performed if there is clinical or neuroradiologic 
evidence for increased intracranial pressure. LP in a patient with a unilateral 
hemispheric or cerebellar lesion may lead to transtentorial or transmagnal 
herniation. Small SAH may be evident in the cerebrospinal fluid but not on 
head CT.
Transcranial Doppler (TCD) is a noninvasive and portable method used for 
imaging the circle of Willis and the vertebrobasilar system. TCD is useful in 
predicting stroke in children with sickle cell disease , and can detect vasospasm 
in SAH.
Evidence for prothrombotic state, coagulopathy or systemic inflammation 
should be carefully investigated. Approximately 30% of children with ischemic 
stroke have abnormalities in their prothrombotic factors. Lactate and pyruvate 
levels should be obtained if mitochondrial disorder is suspected. CSF lactate 
and pyruvate values may be necessary to make the diagnosis, even though 
serum levels are normal. Hemoglobin electrophoresis; VDRL, HIV, and 
varicalla titers; and PPD should be done when clinically indicated.
The diagnostic evaluation should not stop if one risk factor is identified, 
because pediatric stroke patients can have more than one cause for their 
cerebrovascular event. If intracranial hemorrhage is detected, a neurosurgical 
consultation should be obtained.
Conventional angiography should be reserved for patients with nontraumatic 
intracranial hemorrhage or when vasculitis is suspected, if other imaging 
modalities have been normal. Small aneurysms, arteriovenous malformation, or 
cavernous malformations may not show up on MR imaging or MR 
angiography. The angiography may not detect vascular malformations if they 
are surrounded by hematoma and edema. Repeating the angiography or waiting 
until the hematoma has resolved may be necessary in this case.
If there is no evidence for infarction or intracranial hemorrhage, other 
conditions that mimic stroke such as transient postictal hemiparesis, 
migraine, hypoglycemia, and alternating hemiplegia must be excluded.
Figure 25-26. Algorithm showing the evaluation of stroke in 
the pediatric patient. Abbreviations—see text.
REVIEW OF LITERATURE
1.       MEAN AGE OF PRESENTATION
       The mean age of presentation was 5 years in the study by Ganesan 
et al 2003, 4.3 years in the study by Delsing et al 2001, 8.67 years in the study 
by a Gabis et al 2002, 8.2 years in the study by Jennifer et al 2007, 5.6  ± 4.9   
years  in  the  study  by  Cchung  et  al  2004,  6  years  Thethein  the  study  by 
Ssimma et al 2007.
      Higgins JJ et al and Mancini  J et  al stated that  there was a 
preponderance of children less than 6 years of age at the occurrence of arterial 
stroke.
2.       SEX DISPARITY IN INCIDENCE OF CHILDHOOD STROKE
    Ganesan et al 2003 found that 54% were males. Kirkham et al 2004 
and Fullerton et al 2003  stated that stroke is more common in boys. In the 
study conducted by  Cchung et al  2004  male/female ratio was identified as 
1.27:1.
     ,Jennifer et al 2007 stated that males (53.3%) were more likely to be 
affected than females (47.7%). Ssimma et al 2007 found that ,60% were males.
        Delsing et al 2001, Giroud M et al 1993, Higgins JJ et al 1991, 
Powell  FC et  al  1994 and Mancini  J et  al  1997 stated that  male  patients 
slightly, but not significantly, outnumbered females.
3.       SIDE OF LESION
          Lee et al 2008 stated that ,hemiplegia was more common on the 
right side (51%).
         Delsing et al 2001 found that hemiplegia is more common on right 
(59%).
4.       TIME LAG TO FIRST MEDICAL CONTACT
         Gabis et al 2002 stated that  ,time from clinical onset to first 
medical  contact averaged 28.5 hours, and the time to diagnos  e   stroke   averaged   
35.7 hours.
5.       HEMIPLEGIA WITH APHASIA
         Aphasia was an associated feature in 25% of patients in the study 
by Delsing et al 2001, ,28.6% in the study by Obama et al 1994, 11% in the 
study by Jordan et al 2007, 10% in the study by Cchung et al 2004.
6.       HEMIPLEGIA WITH SEIZURES
         Seizure was an associated feature in 29% of patients in the study 
conducted by Lee et al 2008, 19% in the study by Delsing et al 2001, 20% in 
the study by Steinlin et al, 52% in the study by Cchung et al 2004, 27% in the 
study by Jordan et al 2007.
7.       HEMIPLEGIA WITH ALTERED MENTAL STATUS
      Altered sensorium was reported in 16% in the study by  Delsing et 
al 2001, 30% in the study by Cchung et al 2004, 35% in the study by Steinlin 
et al  and , 6% in the study by  
Jordan et al 2007.
8.       HEMIPLEGIA WITH FACIAL NERVE PALSY
      Obama  et  al  1994 found  that 62.9%  had  facial  palsy  as  an 
associated finding.
9.       AGE-RELATED  VARIATION  IN  PRESENTING  SIGNS  OF 
CHILDHOOD ARTERIAL ISCHEMIC STROKE
     Williams et al identified  
The conclusions derived from the study were that 
children  had more  prothrombotic  causes  (25% versus  14%,  p  =  0.03),  and 
young adults had more dissections (3% versus 15%, p = 0.005). 
Children aged 15 to 18 years had causes of ischemic stroke more similar to 
those in young adults. 
The cause of ischemic stroke was less often identified in children than it was in 
young adults. 
Children  had more  prothrombotic  causes  of  stroke,  and  adults  had  more 
atherothrombotic causes and dissections. 
Lacunar strokes were rare in both children and young adults.
     Delsing et al 2001 found that the etiologic factors in children differ 
from those factors  found in  later  life.  Metabolic  causes  causes[2,3],  Moya-
Moya  disease [4],  hematological abnormalities [5],  and  infection-related 
strokes [6] were more common in children than in adults [7-9]. .
10.      FAMILY HISTORY
      Barreirinho et al 2003 stated that only one child had a father with 
myocardial infarction by the age of 45.
      Cchung et al 2004 stated that only 1 patient ,  with moyamoya 
disease  ,  had a family history of stroke.  
11.      SUBTYPES  OF  ARTERIAL  ISCHEMIC  STROKE  IN 
CHILDREN
        Williams et al identified Young adults aged > 18 to 45 years were 
identified  from the  Indiana  University  and  Northwestern  University  Young 
Adults Stroke Registries.  that children had more prothrombotic causes (25% 
versus 14%, p = 0.03), and young adults had more dissections (3% versus 15%, 
p = 0.005). The cause of ischemic stroke was less often identified in children 
than it is in young adults. Lacunar strokes were rare in both children and young 
adults.
       Wraig et al 2005 defined eight aetiological subtypes, as follows: 
(1) sickle cell disease; (2) cardioembolic; (3) moyamoya syndrome; (4) cervical 
arterial  dissection;  (5)  steno-occlusive  cerebral  arteriopathy;  (6)  other 
determined  aetiology;  (7)  multiple  probable/possible  aetiologies;  and  (8) 
undetermined etiology.
12.      ISCHEMIC STROKE
ETIOLOGY/ RISK FACTORS
       Sreckovic  et  al  2004 stated  that , for  the  initial 
stroke,cardioembolic  (33.3%)  and arteriopathic  processes  (36.1%)  were  the 
most  probable  mechanisms  of  arterial  ischemic  stroke.  Prothrombotic 
abnormalities  were  found in 11.1%. Underlying pathology in the remaining 
19.4% was not known.
       Chabrier et al 2000 described that the pathophysiologic process 
could  be  established  for  78%  of  the  children.  Arteriopathic  stroke  (53%)   
was  the  most  common   cause .  The  arteriopathies  were  either   
progressive  (moyamoya  in  7%)  or  nonprogressive  (46%).  The  latter  form   
occurred  in  two  patterns:  dissection  of  cervicocephalic  arteries  (20%)  and   
transient  cerebral arteriopathy of unknown origin but probably angiitis    (25%).   
Cardiac  or  transcardiac  embolic  stroke  occurred  in  12%  of  the  series  and 
systemic diseases in 14%.  . 
        Lee et al 2008 stated that the risk factors included vascular disease 
(33%),  infection  (27%),  metabolic  disorders  (18%),  trauma  (11%), 
prothrombotic states (13%), cardiac disease (10%), and mitochondrial disease 
(6%). Ten percent (n=9) had no identifiable cause. Twenty-two percent22% of 
the children had more than one risk factor. 
                  
Obama  et  al  1994 found  that the  main  etiological  factors  were: 
homozygous  sickle  cell  disease  (31.4%),  heart  disease  (17.1%), 
cerebral malaria (14.3%) and meningitis (14.3%). No causative factor 
was identified in (20%).
                 
 Jordan et al 2007 stated that stroke risk factors could be identified in 93% of 
patients.  The  most  common  risk  factors  were  cardiac  disease,  infection, 
vasculopathy,  trauma  and  hematological  disorders.  Vasculopathy  included 
cerebral  arterial  abnormalities  due  to  moyamoya  disease, HIV, arterial 
dissection and transient cerebral arteriopathy.
       Cchung et al 2004 stated that important causes    included congenital   
heart diseases  ( 30%  ) , vascular diseases  ( 26%) and hematologic    diseases (28%).   
12% had no determined causes.
       Jennifer  et  al  2007 ,, of inenumerated  the  etiologies  as 
cardioembolic  (21.5%),  moyamoya  (16.9%),  carotid  dissection  (10.8%), 
vertebral dissection (10.8%) , prothrombotic (7.7%), post-varicella (3.1%) , and 
(1.5% )  each  of  infection;  pulmonary  arteriovenous  malformation; 
chemotherapy-related stroke; sickle-cell disease; vasculitis; cerebral autosomal-
dominant  arteriopathy  with  subcortical  infarcts  and  leukoencephalopathy 
(CADASIL);  mitochondrial  myopathy, encephalopathy,  lactic  acidosis,  and 
stroke (MELAS); hypertension; and complicated migraine. The etiology was 
unknown in (15.4%).
        R Sträter et al 1999, R Sträter et al 2002, V Ganesan et al 1996 
and U Nowak-Gottl et al 1999 stated that a single thrombophilia does not fully 
explain a stroke in a child, but multiple thrombophilias and thrombophilia in 
patients with cerebral arteriopathy or congenital heart disease confers a higher 
risk of stroke.
13.      
VARICELLA INFECTION 
        Losurdo et al 2006 observed 4 cases of cerebrovascular disease 
after varicella infection.
       R Askalan et al 2001, V Ganesan et al  1997, G Losurdo et al 
2005 and G Sébire et al 1999 showed that children with stroke were 18 times 
more likely to have had chicken pox in the previous 9 months than healthy 
controls were. 
       E Chiappini et al 2002 and E Wirrell et al 2004 observed that .[66]  ,  
[67]  ,    [68]   and   [69]   s  econdary reactivation of varicella zoster virus  had been  associated   
with stroke.  ,70    71  
       MA Nagel et al 2007 confirmed active  varicella zoster virus 
replication in the CNS by PCR or by antibodies in the CSF.
        L.J. Kappelle et al 1989 stated that vasculitis, caused by the direct 
invasion of infectious agents  or by the interaction of  a virus with platelets, 
leading to thrombosis, may account for the development of infarcts.
       Seébire G et al 1999 stated that there was a significant statistical 
link  between  idiopathic  arterial  ischemic  strokes  in  children  and  varicella-
zoster virus infection.
       Hausler et al 1998 reported four previously healthy children with 
VZCV with   Clinical manifestations included ssudden onset of hemiparesis, 
motor aphasia and disturbed consciousness. in previously healthy children. One 
child had a history of chickenpox six weeks prior to the onset of stroke and a 
latency period of up to four years between chickenpox and the onset of stroke 
was found in the other three children. 
       Inagaki et al reported that  9 of 16 young patients  with basal 
ganglionic infarctions had manifested varicella 1-4 months before onset.
        H. Wanifuchi et al 1988 and L. Tucciarone et al 1992 found that 
in unexplained cases of childhood infarctions, episodes of inflammation, such 
as that due to varicella, measles,  s.,  , and  tonsillitis  [12,22,23],  or mild head 
trauma  [12] in the past history have been considered to be possible antecedent 
factors.
14.      MINOR HEAD TRAUMA
        Satoh et al  1991  [12]  reported that 10 of 54 pediatric patients   
with cerebral infarctions had mild head trauma. Stretching of the lateral 
lenticulostriate perforating arteries caused by sudden rotation of the head 
during  injury   was   considered  to  be  a  possible  explanation  for  the  
occurrence of subcortical infarcts   [25] . 
       Kieslich et  al  2002  investigated the  importance  of  traumatic 
endothelial lesions in intraparenchymal end arteries after minor head injuries. 
Minor head injuries can be cause and co-factor in the etiology of stroke.
15.      MULTIPLE RISK FACTORS 
        Lanthier et al 2000 stated that  risk factors were variable and 
multiple in 24% of ischemic strokes. Ischemic stroke recurred in 8% patients 
with a single or no identified risk factor and in 42% of patients with multiple 
risk factors (p = 0.01). No patient with hemorrhagic  stroke had multiple risk   
factors. 
16.      SICKLE CELL ANEMIA
       Oliveira et al 2008 concluded that cerebral infarction affected 
approximately 30% of all individuals with sickle cell anemia. The stroke was 
ischemic in all individuals and the first cerebrovascular event occurred before 6 
years of age. 
       RJ Adams et al 1998 and HJ Fullerton et al 2004 stated that in 
children who were at a particularly high risk of stroke, on the basis of abnormal 
results on transcranial doppler, chronic blood transfusion therapy resulted in a 
90% reduction in relative risk of stroke.
.[37]   and   [38]  
        De baun et al 2006, M Prengler et al 2002 and JJ Strouse et al 2006 
focused on the risk factors for stroke in sickle cell disease that included raised 
blood  pressure,  lower  haemoglobin  concentrations,  high  leukocyte  count, 
previous  transient  ischaemic  attacks,  priapism,  acute  anaemia,  recent  acute 
chest syndrome, or transfusion within the past 2 weeks. 47   48   
         Jordan et al 2007 stated that children with sickle cell disease had 
a markedly   increased risk of both hemorrhagic and ischemic stroke...
17.      ITP 
        Jordan et al 2007 stated in his study that, brain hemorrhage was 
estimated  to  occur  in  0.1%  to  1.0%  of  children  with  idiopathic 
thrombocytopenia purpura. [26].
18.      HEMOPHILIA
        Jordan et al 2007  identified that the prevalence of intracranial 
(epidural, subdural, and parenchymal) hemorrhage in hemophiliac children to 
be between 2.9% and 12% [28],  [29] and [30],  with a median age at onset of 
5.9 months to 2 years.   [28] and  [29].  Trauma  was the most important risk 
factor for intracranial hemorrhage in children with hemophilia [28]..
19.      HEMORRHAGIC STROKE
            Blom et al 1998 suggest that overall mortality from hemorrhagic stroke 
was approximately 25% in children; significant disability  was present in 42% 
of those who survive.
,.[14].20.       RISK  FACTORS  FOR  HEMORRHAGIC  STROKE  IN 
CHILDHOOD
       Al-Jarallah  et  al  1998 and Meyer-Heim 2000 suggest  that 
intraparenchymal  hemorrhage  in  childhood  was most  often  the  result  of 
arteriovenous malformation (14% to 46%), hematologic abnormality, or brain 
tumor.   (Table  2)  [15],  [16] and  [17].  Other  etiologies  include  cavernous 
hemangioma [18],  vasculopathy, vasculitis,  cerebral and systemic infections, 
and rarely, illicit drug use..[9], [12] and [21]. 
       Giroud et al 1993, Al-Jarallah et al 1998 and Meyer-et al 2000 
reported that hematological abnormalities were the major risk factor in 10% to 
30%  of  hemorrhagic   and  include  thrombocytopenia,  hemophilia,  and 
coagulopathies...
21.      ISCHEMIC VS HEMORRHAGIC
       10-year review of the Dijon Childhood Neurology Clinic experience 
(1985-1995) bGiroud et al  1997,  10-year review of  the Dijon Childhood 
Neurology Clinic experience (1985-1995) identified  studied 54 patients with 
arterial  stroke were  identified.  There  were  31  cases  of  ischemic  stroke, 
representing 57% of the total, and 23 cases of hemorrhagic stroke, representing 
43% of the total.
       Lanthier et al 2000 found that 70% of the strokes were ischemic 
strokes and 30% were hemorrhagic strokes.
       Chung et al 2004 stated that 72% were ischemic and  28% were   
hemorrhagic stroke whereas Simma et al 2007 stated that 73% were ischemic 
strokes and 27% were hemorrhagic strokes.
22.      INVESTIGATIONS
       Husson et al 2002 concluded that contrast angiography (CA) was 
the reference examination for the diagnosis of cerebral arterial abnormality, but 
this procedure is invasive. All lesions shown by CA were present on MRA. 
Patients with no lesion on MRA had normal CA. Associated distal vascular 
lesions and degree of arterial stenosis were more accurately detected with CA. 
MRA is sensitive enough to provide an adequate initial evaluation of arterial 
brain disease in childhood.
       Jordan et al 2007 found that a combination of magnetic resonance 
imaging,  magnetic  resonance  angiography,  and  magnetic  resonance 
venography  images  accurately  identified  the  cause  of  intraparenchymal 
hemorrhage  in  66% [40].  Interestingly,  in  the  same  study,  conventional 
cerebral angiography alone had a diagnostic yield of 61%. .
       Ganesan et al  1999  suggest  that conventional  cerebral 
angiography  has  a  continuing  role  in  the  identification  of  potentially 
treatable cerebrovascular abnormalities in children with ischemic stroke 
which include  moyamoya  syndrome [1,2],  arterial  dissection [3], and 
cerebral vasculitis. and remains mandatory for preoperative evaluation. 
MRA is a sensitive imaging modality for moyamoya syndrome, for the 
detection of large vessel stenosis and occlusion, for screening patients 
at  risk [5-7],  for  serial  monitoring  in  patients  who  are  known  to  be 
affected  or  after  surgery [8],  for  arterial  dissection especially  in 
combination with duplex ultrasound of the carotid vessels in the neck 
[3,9] and  for children  with  sickle  cell  disease for  whom MRA  and 
transcranial Doppler ultrasound individually have demonstrated a high 
sensitivity  and  specificity  compared  with  conventional  angiography 
However,  the resolution of  MRA only permits examination of  vessels 
with  a  diameter  of  1mm [13], and  detection  of  abnormalities  in  the 
posterior circulation is relatively poor [11].
23.      THROMBOLYTIC THERAPY IN ISCHEMIC STROKE
       Kirton et al (2008) by Kirton et al (2008)  reported that only 1.6% 
of children with arterial ischemic stroke were given thrombolytics in the United 
States [2].  Consistent with this are studies demonstrating long delays in the 
diagnosis  of  childhood  stroke,  and  report  that  the  majority  of  children  are 
ineligible  to  receive  thrombolytic  therapy  according  to  adult  thrombolysis 
criteria [3].  The  benefits of intravenous thrombolysis are lost beyond 3 hours 
[5] and  any benefit  is overcome by an increasing incidence of symptomatic 
intracerebral  hemorrhage.  Anticoagulation  and  antiplatelet  approaches  to 
treatment,  as  well  as  neuroprotective  strategies,  are  supported  by  these 
guidelines and existing safety data, whereas thrombolytics are not [10].
24.      PROGNOSTIC FACTORS
ISCHEMIC VS HEMORRHAGIC 
       Schoenberg et al 1978 stated that although  children with cerebral   
infarction had better survival,  they  experienced more residual disability  than   
children with cerebral  hemorrhage.  
       Cchung et al 2004 stated that 13.9% with ischemic stroke and 26% 
with hemorrhagic stroke died. Decreased level of consciousness was significant 
risk factor associated with high mortality rates.
       Lanthier et al 2000 stated that  risk factors were variable and 
multiple in 24%  of ischemic strokes. Ischemic stroke recurred in 8%   of patients   
with a single or no identified risk factor and in 42% of patients with multiple 
risk factors (p = 0.01). No patient with hemorrhagic  stroke had multiple risk   
factors. Hemorrhagic stroke recurred  in two patients (10%).  
25.      PREDICTORS OF LONG TERM MORBIDITY
        Schoenberg et al 1978 stated that although  children with cerebral   
infarction had better survival,  they  experienced more residual disability  than   
children with cerebral  hemorrhage.  
     In the study by De Veber et al 2000, the primary outcome 
based on Pediatric Stroke Outcome Measure assessment (PSOM) was 
stated as: normal, 37%; mild deficit, 20%; moderate deficit, 26%; and 
severe deficit, 16%. Poor outcome in children after ischemic stroke was 
frequent and more likely in the presence of arterial stroke, rehabilitation 
therapy  and  associated  neurologic  disorders,  which  justifies  clinical 
trials of treatment strategies in childhood ischemic stroke.
       Cchung et al 2004 stated that long-term neurologic deficits 
occurred among  41% of survivors, including mental retardation, epilepsy   
,  and hemiplegia. For 82% who survived, the only significant risk factor   
for  long-term neurologic deficits was seizures at the initial presentation.   
Other factors, such as gender, age, other clinical features,  stroke type,   
vascular  territory,  other  causes,  and  recurrence   of  stroke,  were  all   
insignificant for both death and long-term  deficits.  
       Lanthier et al . [9] reported that the coexistence of multiple 
stroke risk factors in children predicted poor outcome.
26.     PREDICTORS OF MORTALITY
       Cchung et al 2004 stated that 13.9% with ischemic stroke 
and  26%  with  hemorrhagic  stroke died.  Decreased  levels  of 
consciousness, hematological causes and hemorrhagic  transformation   
(applicable  only  in  ischemic  stroke)  were  significant   risk  factors   
associated with high mortality rates.
       Delsing  et  al  2001 stated  that death  occurred 
more  frequently in patients with recurrent stroke (40%) than in those    with   
nonrecurrent stroke (16%).
       Dusser et al. [16] stated that children with idiopathic strokes 
had a  better  prognosis,  with  minor  residual  deficits,  in  contrast  with 
severe  neurologic  residual  impairment  in  children  after  stroke  in 
association with  cardiac  disease.  Alteration of  consciousness with  or 
without seizures was reported to be a significant risk factor of immediate 
death after arterial stroke. [17,18].
27.    PREDICTORS OF RECURRENCE
       Lee et al 2008 stated that 16% had recurrent stroke, 60% of 
whom had underlying vascular disease. The vascular disease included 
moyamoya disease, CNS lupus and ill-defined vasculopathy.
       Delsing  et  al  2001 stated  that 22%  had  one  or  two 
recurrences. 
       Lanthier et al 2000 stated that risk factors were variable and 
multiple in 24% of ischemic strokes. Ischemic stroke recurred in 8% of 
patients with a single or no identified risk factor and in 42% of patients 
with multiple risk factors (p = 0.01). No patient with hemorrhagic  stroke   
had multiple risk factors.  Hemorrhagic  stroke recurred  in  two patients   
10%.
        Sreckovic et al 2004 stated that recurrent ischemic infarction was 
diagnosed in 13.9%. The risk of recurrence appeared to be fivefold higher in 
children  with  cardiac  disease  irrespective  of  the  coexistence  of  other  risk 
factors. 
       Chabrier et al 2000 found that there was a favorable outcome in 
70% of patients having stroke  due to nonprogressive arterial disease and stroke   
due to unidentified mechanisms. In contrast, only 26% of patients with embolic 
stroke,  systemic  disease  or  moyamoya  had  a  favorable  outcome.   
Recurrences  were more frequent and severe in this latter group.  
        Ganesan et  al  2006  concluded that  clinical  and radiological 
recurrences were common after childhood AIS. The risk of clinical recurrence 
was high in children with moyamoya and in those with genetic thrombophilia. 
Preexisting pathology, including immunodeficiency and persistent leukocytosis 
was a risk factor for radiological recurrence.
        Fullerton et al 2007 studied the risk of recurrence in hemorrhagic 
stroke (HS). Overall, 10% children with HS experienced  a recurrence within 5   
years, despite available therapies. Whereas  idiopathic HS rarely recurred  ,   HS   
due to medical etiologies  tended to recur acutely   and  children with structural  
lesions had  a high and prolonged risk for recurrence.  
        Lynch et al  2004  reviewed that  up to  one third will  have a 
recurrent stroke. 
28.      . COGNITIVE OUTCOME
       De Schrijver et al. [15] concluded that global cognitive functioning 
in children after arterial stroke was shifted toward lower levels.
       Delsing et al 2001 stated that ,attention is impaired after childhood stroke 
and  poorer  performance  was associated  with  an  earlier  age  of  stroke.109   
Intellectual  impairment  was common  in  children  with  stroke  that  was 
associated with sickle cell disease. 108  The laterality of stroke does not influence   
neuropsychological  outcome,  and  there  was no  clear  relation  between  the 
location of stroke and cognitive outcome.107    
29.      OUTCOME, LONG TERM FOLLOW UP AND QUALITY OF 
LIFE
       Chabrier et al 2000 found that there was a favorable outcome in 
70% of patients having stroke  due to nonprogressive arterial disease and stroke   
due to unidentified mechanisms. In contrast, only 26% of patients with embolic 
stroke,  systemic  disease  or  moyamoya  had  a  favorable  outcome.   
Recurrences  were more frequent and severe in this latter group.    More than a   
half of children with AIS will have neurological sequelae.105   
      Obama et al 1994 stated that ,were studied from August 1984 to 
July  1990,  the  mortality  rate  as  low  (2.9%)  and  all  the  children  had 
neurological deficit after a mean hospital stay of 15 days. 
      Lanthier et al 2000 stated the outcome as follows: asymptomatic, 
36%,  symptomatic  epilepsy  or  persistent  neurologic  deficit,  45%    and death,   
20%.
      Simma et al 2007 stated that 55% had a good overall outcome, with 
no neurological symptoms, normal intelligence test scores and normal quality 
of  life (Table  3).  In  the  remaining  nine  children  (45%)  with  poor  overall 
outcome, all had severe or moderate clinical neurological deficits. (Table 4).
30.      FUTURE STUDIES NEEDED
       Jordan et al 2001 stated that while research in arterial ischemic 
stroke and cerebral venous sinus thrombosis is expanding, hemorrhagic stroke 
in children remains largely unstudied. There is a paucity of literature to guide 
physicians who care for children with hemorrhagic stroke. Additional work is 
required  in  hemorrhagic,  as  well  as  arterial  ischemic  stroke  in  childhood. 
Randomized controlled trials of intervention will be essential. In hemorrhagic 
stroke,  particularly  important  data  that  are  required  to  plan  randomized 
controlled trials include recent population-based data on incidence and etiology 
of childhood hemorrhagic stroke; information on time to presentation that may 
affect  therapeutic  options;  detailed  information  on  neurologic  outcome  and 
predictors of outcome; and Phase I and II treatment trials that include children.
                                   
JUSTIFICATION OF THE STUDY
               Stroke in children differs from stroke in adults by the 
rarity, subtle presentation and wide differential diagnosis (Coagulation, 
vascular & neurological systems. 
               Risk factors are multiple, age-related and poorly 
understood and there is no established treatment protocol. 
              Impact of pediatric stroke is great with mortality up to 
10%, risk of recurrence of arterial stroke upto 20 to 30%, risk of death, 
disability,  reduced quality  of  life  upto 50% (Seizures 15%, headache 
disorders 30%, neurologic deficits 60%). 
              Identification  of  the cause of  pediatric  stroke  is 
increasing  due  to  the  availability  of  more  sensitive  imaging  and  the 
incidence is increasing due to  effective management  of  predisposing 
conditions (CHD, prematurity, tumors).
           
AIM OF THE STUDY
              Aim of the present study is to identify etiology of stroke in 
children in our part of world, to assess the mortality and morbidity and to 
follow them up for 1 to 2 years to recognize complications.
                                            
MATERIALS AND METHODS
STUDY DESIGN   
Prospective cohort study
STUDY PERIOD    
October 2006 - September 2008
STUDY PLACE         
Department of Neurology, Institute of Child Health, Chennai
SAMPLE SIZE         
68
INCLUSION CRITERIA
        Acute motor weakness involving one half of the body in 
children between 2 months to 12 years, presenting within 3 weeks from 
the onset.
EXCLUSION CRITERIA
1. Old cases with history more than 3 weeks from the onset  
2. Those with weakness lasting less than 24 hours  
METHODOLOGY
       The present study was conducted in the Institute of  Cchild 
Hhealth and Hhospital for children, Chennai. 68 children who rangeding 
in age from 2 months to 12 years,  who presenteding with weakness 
involving  oof  one  half  of  the  body, (hemiplegia) with  onset  within  3 
weeks of onset, were included in the study. The children were admitted 
in medical wards. Initial resuscitation was done by stabilizing the airway, 
breathing  and circulation, control  of  seizures  with  anti  epileptics and 
appropriate anti edema measures for raised intracranial tension. Since 
all the children included in the present study presented beyond 3 hours 
from  the  onset  of  weakness,  none  were  subjected  to  thrombolytic 
therapy. 
        A detailed history  of the presenting illness  was obtained 
including  the  onset, distribution, progression  of  weakness,  seizures, 
fever,  headache,  vomiting,  altered  level  of  consciousness,  aphasia, 
cranial  nerve  palsies,  extrapyramidal  movements and sensory 
involvement.
        History of  head trauma, neck trauma, recent  infection, 
illness,  unexplained fever  or malaise and drug ingestion,  if  any,  was 
also  obtained.  Significant past history,  antenatal,   and  developmental 
history  were  obtained.  and  iInformation  regarding  demographic  data 
were  as  collected.  Careful  family  history,  with  special  attention  to 
premature  vascular  disease,  hematologic  disease and, mental 
retardation was elicitedobtained. 
     Physical  examination  including  head  circumference in 
children, neurocutaneous markers, cardiac evaluation, and palpation of 
carotid arteriesy and a detailed neurological examination was done. 
Severity of motor weakness was graded as below.
1. M  ild – near normal power, abnormal gait and arm drift  . 
2. M  oderate – significant weakness interfering   with   activities  
of daily living.
3. P  rofound  –   dependan t for ambulation or bed ridden  .        
       History of head trauma, neck trauma, recent  infection,  illness, 
unexplained fever or malaise and drug ingestion, if any, was obtained. 
Significant  past  history,  antenatal  and  developmental  history  were 
obtained.  Information  regarding  demographic  data  was  collected. 
Careful  family  history,  with  special  attention  to  premature  vascular 
disease,  hematologic  disease,  mental  retardation was  obtained. 
Physical  examination including  head  circumference  in  children, 
neurocutaneous  markers,  cardiac  evaluation  and  carotid  artery 
examination and  a  detailed  neurological  examination was  done.  All 
children were subjected to neuroimaging MRI and MRA. Further workup 
was tailored based on the findings in neuroimaging. 
      All children were subjected to neuroimaging (MRI and MRA). 
Further workup was tailored based on the findings in neuroimaging.  If 
the  MRI  and  MRA  reveal  an  infarct,  with  vascular  distribution,  then 
following  diagnostic  tests were  performed  -  Echocardiogram,  EKG, 
blood  studies  including  CBC,  Protein  S,  Protein  C,  Antithrombin  III, 
homocysteine, lipid profile, antiphospholipid antibody, infection screen, 
tuberculosis screening, lumbar puncture and transcranial Doppler.
      If  the MRI and MRA reveal  an infarct,  with  non-vascular 
distribution, serum         lactate and pyruvate were done.
      If the MRI and MRA reveal a hemorrhage, then  studies to 
screen for coagulation  disorders were done like bleeding time, clotting 
time, prothrombin time and partial  thromboplastin  time.  If  the results 
were abnormal, then studies like factor VIII assay, factor XI assay, to 
rule out specific coagulation disorder were obtained.
     Presenting symptoms and underlying etiology were analyzed 
and children were categorized based on the etiology.
       All surviving children were neurologically examined, at the 
end  of  the  follow-up  period of  1  –  2  years, to  determine  residual 
impairment. Determination  of  residual  impairment  in  each  child  was 
based on the  findings  at  neurological examination  at  the end of  the 
follow-up period.       Outcome was considered favorable when children 
had no residual impairment.
 Outcome  was  considered  unfavorable  when  children  had  residual 
impairment or have died.
       Statistical  analysis was  done  and  the  relation  of  each 
variable  to  outcome categories  was  analysed  separately  by the  chi-
square test. . (Chicago, IL). 
OBSERVATION AND RESULTS
1.      SEX DISPARITY  
      In the present study, 42% of the cases were males and 58 % 
were  females,  which  is  statistically  not  significant  (chi-square test - 
p=0.145) (Picture. 1)..
2.      MEAN AGE AT ONSET
     In the present study, the mean age at the onset of hemiplegia 
was 4.4 years.
3.       SIDE OF LESION
      In the present study, 52% of cases had right sided hemiplegia and 
48% had left sided lesion, which is statistically not significant (chi-square test - 
p=0.808). (Picture. 2).
4.       TIME LAG FOR FIRST MEDICAL CONTACT
      The average time lag from the onset of weakness to first medical 
contact in our study is 70 hrs.
5.       PAST HISTORY
      In the present study, 2 cases had a history of chicken pox 3 months 
before the onset of hemiplegia, one case had chicken pox 15 days before and 
one case had a history of measles 15 days back.
6.       FAMILY HISTORY
      In the present study, 1 case had a family history of recurrent stroke 
in father and the child presented with regression of milestones.
7.       HEMIPLEGIA WITH APHASIA
      In the present study, 28.5% with right sided weakness had aphasia 
whereas 9% with left sided weakness had aphasia.
8.       HEMIPLEGIA WITH SEIZURES
      In the present study, 41% of the cases had seizures either focal or 
generalized and 59% of the cases were seizure free.  Among the patients who 
had seizures, 68% had residual motor weakness whereas only 60% of cases 
who were  seizure  free  had residual  weakness. Association  of  seizures  with 
neurological outcome is not statistically significant (p=0.508) (Picture. 3)..
Seizures Number Good 
outcome
Poor 
Outcome
X2=0.437
Focal or generalized 
seizures
28(41%) 9(32%) 19(68%)
p=0.508
NSNo seizures 40(59%) 16(40%) 24(60%)
NS – not significant 
9.       HEMIPLEGIA WITH FACIAL PALSY
     In the present study 39.7% of patients with hemiplegia had facial 
palsy
10.      CONSCIOUSNESS
       In the present study, at the onset of illness,  10.3% of cases were 
drowsy and 7.3% of cases were unconscious. 85.3% of cases who were drowsy 
at the onset and 80% of cases who were unconscious at the onset had residual 
weakness  whereas  only  55%  of  patients  who  were  alert  at  the  onset  had 
residual  weakness. Association  of  altered  level  of  consciousness  with 
neurological outcome is statistically not significant (p=0.195) (P.icture. 4).
Consciousness Number Good 
outcome
Poor 
outcome
X2=3.270
Alert 56(82.4%) 25 (45%) 31 (55%)
p=0.195
NS
Drowsy 7(10.3%) 1 (14.2%) 6 (85.3%)
Unconscious 5(7.3%) 1 (20%) 4 (80%)
NS – not significant 
11.      SEVERITY OF MOTOR WEAKNESS
      In the present study, 67.4% of patients with moderate weakness and 88.5% of 
cases with severe weakness had residual weakness whereas only 35.7% of cases 
with mild weakness had residual weakness. (Picture . 5).
Severity of 
motor weakness
Number Good 
Outcome
Poor 
outcome
X2=6.92887
Mild 14(20.6%) 9 (64.3%) 5 (35.7%)
p=0.031
S
Moderate 46(67.6%) 15 (32.6%) 31 (67.4%)
Severe 8(11.8%) 1 (12.5%) 7 (88.5%)
S - significant
12.      NEUROIMAGING 
      In the present study, MRI revealed infarct in 83.8%, hemorrhage in 10.328.5% 
and space occupying lesion in 5.9%. 
MRI Number
Infarct 59(83.8%)
Hemorrhage 5(10.3%)
SOL 4(5.9%)
13.      BLOOD COUNT
Peripheral smear Number Good outcome Poor outcome
Anemia 17 9 8
Leukemia 1 0 1
Thrombocytopenia 1 0 1
Polycythemia 3 0 3
14. CAUSES OF HEMIPLEGIA
        The table below shows the observation of the etiology of hemiplegia in the 
present study. Underlying cardiac disorder, either congenital or acquired was 
observed in 16% of cases and was the most common risk factor followed by 
prothrombotic factors in 14.7%, which is statistically significant (chi-square test - 
p=0.036). Multiple risk factors were observed in 16% of cases 
(Picture. 7 & 8)..
Eitiology Number Good 
Outcome
Poor 
outcome
Cardiovascular
Cyanotic CHD
Acyanotic CHD
Valvular heart 
disease
RBBB
Cyanotic CHD 4 0 4
Acyanotic CHD 4 0 4
Valvular heart disease 2 2 2
RBBB 1 1 0
Prothrombotic
Protein C 
deficiency
Protein S 
deficiency
APLA
Homocystinuria
Protein C deficiency 0 0 0
Protein S deficiency 4 3 1
APLA 4 1 3
Homocystinuria 2 0 2
Vascular
Nonspecific 
Vasculitis
Moya moya 
disease
Hypoplasia of 
ICA/MCA
Nonspecific Vasculitis
3 2 1
Moya moya disease 2 0 2
Hypoplasia of ICA/MCA 3 0 3
Anemia
Sickle cell
Thalassemia 
major
Iron deficiency 
anemia
Sickle cell 1 0 1
Thalassemia major 2 1 1
Iron deficiency anemia 1 1 0
Minor head injury 4 3 1
Multiple risk 
factors
11 4 7
Bleeding
ITP
VWD
Late HDN
ITP 1 0 1
VWD 1 0 1
Late HDN 1 0 1
Space occupying 
lesion
Tuberculoma
Pilocytic 
astrocytoma
Tuberculoma 3 3 0
Pilocytic astrocytoma 1 0 1
Infections
Bacterial 
meningitis
Tuberculous 
meningitis
Bacterial meningitis 1 0 1
Tuberculous meningitis 1 0 1
Encephalitis 1 0 1
Attico antral cholesteatoma 1 1 0
Encephalitis
Attico antral 
cholesteatoma
Metabolic
Mitochondrial
Mitochondrial 1 1 0
Not known 8 7 1
15.    CLASSIFICATION OF CAUSES OF HEMIPLEGIA STROKE
      In the present study, 769.4% of cases were ischemic stroke, 
170.3% were hemorrhagic stroke, 5.8% were  due to  space occupying 
lesions,  5.8%  were  due  to  infective etiology and  1.7%  was due  to 
metabolic cause. (Picture. 9).
Causes Number Percentage
Ischemic 54 769.4%
Hemorrhagic 5 107.3%
Space  occupying 
lesion
4 5.8%
Infective 4 5.8%
Metabolic 1 1.7%
16.    CAUSES OF ISCHEMIC STROKE
      In the present study, multiple risk factors were identified in 
20.3% of ischemic stroke and cause was not identified in 11.1%.
Causes of ischemic infarct Number Percentage
Single cause 37 68.6%
Multiple cause 11 20.3%
Cause not known 6 11.1%
16A.  ISCHEMIC STROKE - MULTIPLE CAUSES   
       The multiple risk factors that were observed in 11 cases 
(20.3 %)  and their outcome with regard to motor weakness  are listed 
below.
Multiple causes Outcome
Protein C, protein S, APLA Good
Moya moya, homocystinuria Poor
Beta thalassemia, sickle cell Poor
APLA, dyslipidemia Poor
MVP, positive family history Poor
Endocardial  cushion  defect,  PHT,  right  MCA Poor
hypoplasia
TGA, VSD, IE Poor
Protein S, APLA Good
APLA, lactate, pyruvate Good
Protein C, protein S Poor
Lactate, pyruvate, triglycerides Good
    Among patients  with  multiple  risk factors,  63.7%  had poor 
outcome.
Number Good 
outcome
Poor 
outcome
X2
p=0.366
NS
Multiple risk factors 11 4 (36.3%) 7 (63.7%)
16B.  ISCHEMIC STROKE - SINGLE CAUSE
    In the present study, 20.4% of cases had underlying cardiac 
disorder, either congenital or acquired followed by prothrombotic factors 
identified in 18.5% of cases, vascular etiology in 14.8%, miscellaneous 
causes in 14.8%, multiple risk factors in 20.4% and cause unknown in 
11.1%.
Causes of ischemic stroke Numbe
r
Percentage
Cardiovascular
Cyanotic  heart 
disease
Acyanotic  heart 
disease
Valvular  heart 
disease
RBBB
Cyanotic heart disease 411
4
11(20.4%)
Acyanotic heart disease 4
Valvular heart disease 2
RBBB 1
Prothrombotic
Protein c
Protein s
APLA
Homocystinuria
Protein C 010
0
10(18.5%)
Protein S 4
APLA 4
Homocystinuria 2
Vascular eitiology
Nonspecific 
vasculitis
Moya  moya 
syndrome
Hypoplasia  of 
ICA/MCA
Nonspecific vasculitis 8
3
8(14.8%)
Moya moya syndrome 2
Hypoplasia of ICA/MCA 3
Anemia
Sickle cell anemia
Thalassemia 
major
Iron  deficiency 
anemia
Sickle cell anemia 5
1
4(7.4%)
Thalassemia major 2
Iron deficiency anemia 1
Minor head injury 4 7.4%
Multiple causes 11 20.4%
Not known 6 11.1%
17.    CAUSES OF HEMORRHAGIC STROKE
       In the present study 60% of hemorrhagic stroke were due to 
blood dyscrasias and  in  40% of cases, cause could not be identified 
(Picture. 10)..
Causes of hemorrhagic stroke
Causes of hemorrhagic stroke
Number Percentage
Blood 
dyscrasia
s
Blood dyscrasias
Idiopathic  thrombocytopenic 
purpura
1
60%
Von Willebrands disease 1
Late  onset  hemorrhagic  disease 
of newborn
1
Not 
known
Not known 2 40%
18.    SPACE OCCUPYING LESION
     Space occupying lesion accounted for 5.8% of cases, 75% of 
which  were  due  to  tuberculoma  and  25%  were  due  to  pilocytic 
astrocytoma.
Cause Number Good 
outcome
Poor outcome
Tuberculoma 3 3 0
Pilocytic astrocytoma 1 0 1
19.  INFECTIOUS ETIOLOGY  
20.
        Infection accounted for 5.8% of cases, 2 cases were due to 
meningitis, 1 case was due to encephalitis and 1 case was due to 
atticoantral cholesteatoma.
Cause Number Good 
outcome
Poor outcome
Bacterial meningitis 1 0 1
Tuberculous meningitis 1 0 1
Encephalitis 1 0 1
Attico  antral 
cholesteatoma
1 1 0
20.      OUTCOME
       In the present study, 60.2% had residual weakness on follow up lasting for a 
period of 1 to 2 years. Among children with ischemic infarct 44.4% had no motor 
deficit and 55.6% had residual weakness. Among children with hemorrhagic 
infarct 20% had no residual weakness and 80% had residual weakness. Among 
cases with space occupying lesion all the cases with tuberculoma had no residual 
weakness and the one with pilocytic astrocytoma had residual weakness. Among 
cases with infectious etiology, the one due to cholesteatoma had no residual 
weakness and cases with meningoencephalitis had residual weakness.
Cause Number of 
cases
Good outcome Poor outcome
Ischemic 54(79.4%) 24(44.4%) 30(55.6%)
Hemorrhagic 5(7.3%) 1(20%) 4(80%)
Space occupying lesion 4(5.8%) 3(75%) 1(25%)
Infectious 4(5.8%) 1(25%) 3(75%)
Metabolic 1(1.7%) 1(100%) 0
        Mortality occurred in 2 cases (3%). One of them was a 5 year old child, a  
case of cyanotic congenital heart disease (transposition of great arteries) with 
infective endocarditis and had infarct in MCA territory. The other was a 4 year 
old child who died on the day of admission, in whom the cause of hemiplegia 
was not identified. 
21.      RECURRENCE OF STROKE
     In the present study, 1 case (3%) with homocystinuria had recurrence 
of stroke on follow up.
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DISCUSSION
1.       MEAN AGE AT ONSET
     The mean age at the onset of the present study is 4.4 yrs compared the studies 
mentioned below. 
Study Mean age of presentation
Ganesan et al (2003) 5
Delsing et al (2001) 4.3
Gabis et al (2002) 8.67
Jennifer et al (2007) 8.2
Chung et al (2004) 5.6
Simma et al (2007) 6
Present study 4.4 yrs
2.       SEX DISPARITY
      In the present study, the percentage of males among the 68 cases was 42%, in 
contrast with other studies mentioned below showing a male preponderance. 
Study Percentage of males
Ganesan et al (2003) 54%
Delsing et al (2001) 50%
Jennifer et al (2007) 53.3%
Chung et al (2004) 56%
Simma et al (2007) 60%
Present study 42%
3. SIDE OF LESION
      Right sided hemiplegia is more common in the present study which 
correlates with the observation of Lee et al (2008) and Delsing et al (2001).
Study Side of lesion
Lee et al (2008) 51% right
Delsing et al (2001) 59% right
Present study 52% right
4.       TIME LAG FOR FIRST MEDICAL CONTACT
      The average time lag from the onset of weakness to first medical contact in our 
study is 70 hrs. Gabis et al (2002) observed the same to be 28.5 hrs. The benefits of 
intravenous thrombolysis are lost beyond 3 hours. After this time, any benefit is 
overcome by an increasing incidence of symptomatic intracerebral hemorrhage. 
Hence majority of children are ineligible to receive thrombolytic therapy according 
to adult thrombolysis criteria.
Study Time from clinical onset to 
medical  contact  
Gabis et al (2002) 28.5 hours
Present study 70 hrs
5.       FAMILY HISTORY
     Family history of stroke was obtained in 1.5% of the cases in the present study 
which correlates with the observation of Barreirinho et al (2003) and chung et al 
(2004) stating that a positive family history of stroke or myocardial infarction is 
not obtained in majority of the cases.
Study Family history
Barreirinho et al (2003) 5% myocardial infarction
Chung et al (2004) 1% stroke
Present study 1.5% stroke
6.       HEMIPLEGIA WITH APHASIA
      Aphasia is an associated feature in 19% of cases in the present study. 
In contrast  
Delsing et al (2001) and Obama et al (1994) observed that higher percentage of the 
patients had aphasia whereas Jordan et al (2007) and chung et al (2004) observed 
that lesser percentage of the patients had aphasia.
Study Aphasia
Delsing et al (2001) 25%
Obama et al (1994) 28.6%
Jordan et al (2007) 11%
Chung et al (2004) 10%
Present study 19%
7.       HEMIPLEGIA WITH SEIZURES
      In the study conducted by  chung et al 2004 long-term neurologic 
deficits occurred among  41% of survivors, the only significant risk factor for   
long-term neurologic  deficits  was  seizures  at  the  initial  presentation.   Other   
factors,  such  as  gender,  age,  other  clinical  features,   stroke  type,  vascular   
territory, other causes, and recurrence  of stroke, were all insignificant for both   
death and long-term  deficits.  
Study Long-term neurologic deficits 
associated with seizures
Lee et al (2008) 29%
Delsing et al (2001) 19%
Steinlin et al 20%
Chung et al (2004) 52%
Jordan et al (2007 27%
Present study 41%
8.       CONSCIOUSNESS
       In  the  present  study,  17.6%  of  cases  presented  with  altered 
consciousness,  83.3%  of  whom had  residual  weakness. This  observation 
correlates with that  of   Chung et  al  2004 and  Dusser et  al who stated that 
decreased level of consciousness was a significant  risk factor    associated with   
high morbidity and mortality rates.
Study Altered mental status
Delsing et al (2001) 16%
Chung et al (2004) 30%
Steinlin et al 35%
Jordan et al (2007) 6%
Present study 17.6%
9.       HEMIPLEGIA WITH FACIAL PALSY
     In the present study 39.7% of patients with hemiplegia had facial palsy in 
contrast with the study done by Obama et al (1994) who observed facial palsy in 
62.9% of the cases. 
Study Facial paralysis
Obama et al (1994) 62.9%
Present study 39.7%
10.      NEUROIMAGING
      In the present study, all the patients enrolled had abnormalities in MRI which 
correlates with the study done by Liu GT et al (1990).
Study MRI abnormalities
Liu GT et al (1990) 100%
Ganesan et al (2003) 91%
Jordan et al (2007) 80%
Present study 100%
11.      HEMORRHAGIC STROKE
        Hemorrhagic stroke as the cause of hemiplegia is around 7.3% in contrast 
with the studies mentioned below. The cause of hemorrhagic stroke as found in 
other studies is sickle cell anemia and moyamoya syndrome – both of which 
present at hemorrhagic stroke in children more than 15 yrs of age. Since the 
present study included children upto 12 yrs of age, the percentage of hemorrhagic 
stroke is significantly less.
Study Hemorrhagic stroke
Chung et al (2004) 28%
Simma et al (2007) 27%
Lanthier et al (2000) 29%
Giroud et al (1997) 43%
Present study 7.3%
12.      EITIOLOGY OF ISCHEMIC STROKE
      In the present study 20.4% of the cases are due to cardioembolic cause, 18.5% 
are due to prothrombotic factors, 14.8% are due to arteriopathy, 14.7% are due to 
others, 11.2% are due to unknown factors and 20.4% are due to multiple risk 
factors. 
Study
Cardio
embolic
Pro
thrombotic
Arteriopathy
Others
s
Unknown
Multiple 
risk 
factors
De Veber et al 38%
Bonduel et al 
(1999)
30%
Heller et al 
(1999)
31%
Simma et al 
(2007)
50%
Giroud et al 
(1997)
19 12.9
Williams et al 15% 25% 36% 24%
Sreckovic et al 
(2004)
33.3% 11.1% 36.1% 19.4%
Chabrier et al 
(2000)
12% 13% 53% 22%
Lee et al 
(2008)
10% 13% 33% 34% 10% 22%
Delsing et al 
(2001)
19% 12.9% 26% 19.1% 23%
Obama et al 17.1% 20%
Study
Cardio
embolic
Pro
thrombotic
Arteriopathy
Others
s
Unknown
Multiple 
risk 
factors
(1994)
Chung et al 
(2004)
30% 26% 28% 4% 12%
Lanthier et al 
(2000)
24%
Present study 20.4% 18.5% 14.8% 14.8% 11.1% 20.4%
13.      MULTIPLE RISK FACTORS
      In the present study, 16.1% of cases had multiple risk factors. 63.7% 
of children with multiple risk factors had poor outcome which correlates with 
the study done by Lanthier et al who stated  thatstated that the coexistence of 
multiple stroke risk factors in children predicts poor outcome.
      In the study by Williams et al 24% had multiple risk factors, 22% in 
the study by Lee et al (2008) and 24% in the study by Lanthier et al (2000).
Multiple risk 
factors
Number Good outcome Poor outcome
Present study 11 4 (36.3%) 7 (63.7%)
13.      HOMOCYSTINURIA
      In the present study 4.4% of the patients had homocystinuria which is in 
contrast to the study by Beynum et al (1999) in which 18% had homocystinuria.
Study Homocystinuria
Beynum et al (1999) 18%
Present study 4.4%
14.      PROTEIN S DEFICIENCY
      Protein S deficiency was observed in 10.2% of cases, which correlates with the 
observation of Usman et al (2007) and De Veber at al.
Study Protein S deficiency
Usman et al (2007) 13.5%
De Veber at al 11.5%
Present study 10.2%
15.      PROTEIN C DEFICIENCY
     Protein C deficiency was observed in 2.9% of cases in contrast to the 
study by Usman et al (2007), Heller et al (1999) and De Veber at al.
Study Protein C deficiency
Usman et al (2007) 5.4%
Heller et al (1999) 7%
De Veber at al 7%
Present study 2.9%
16.      SICKLE CELL ANEMIA
      The age of occurrence of  first  stroke in children with sickle cell 
anemia  in  the  present  study  is  before  6  yrs  which  correlates  with  the 
observation by Oliveira et al (2008).
Study Sickle cell anemia age of 
presentation
Oliveira et al (2008) <6 yrs
Present study <6yrs
17.      OUTCOME
      In the present study, 60.2% had residual weakness which correlates 
with deVeber et al (2000).
      In contrast, Lanthier et al (2000), Chung et al (2004), Delsing et al 
(2001) observed that only around 30% of cases had residual weakness.
      In the present study, only 3% of cases died which correlates with the study of 
Obama et al (1994).
Study Motor deficit Death
Lanthier et al (2000) 36% 20%
Schoenberg et al 75% 16%
Obama et al (1994) 100% 2.9%
DeVeber et al (2000) 63%
Simma et al (2007) 45% 0%
Chung et al (2004) 30% 18%
Jordan et al 16%
Lee et al (2008) 9%
Delsing et al (2001) 29% 13%
Present study 60.2% 3%
18.      RECURRENT STROKE
     In the present study, 1 case (3%) with homocystinuria had recurrence of stroke 
on follow up. This correlates with the observation of Simma et al (2007). The 
incidence of stroke may also be related to the duration of follow up.
Study Overall Recurrent stroke
Lee et al (2008) 16%
Lanthier et al (2000) 24%
Sreckovic et al (2004) 13.9%
Chabrier et al (2000) 20%
Simma et al (2007) 4%
Delsing et al (2001) 22%
Ganesan et al (2006) 41%
Fullerton et al (2007) 10%
Strater et al (2002) 6.6%
Lynch et al (2004) 33%
Becker et al (2002) 6.6%
Lanska et al (1991) 19%
Bonduel et al (2006) 1.1%
Present study 3%
                                                                   
SUMMARY
1. 68 children with hemiplegia (2 months to 12 years) were studied.  
2. There  was  no  significant  difference  in  the  incidence  of  hemiplegia   
between males and females (42% males vs 58% females).
3. There was no significant difference in the side of hemiplegia (52% right   
hemiplegia vs 48% left hemiplegia).
4. Past history of chicken pox was found in 4.4% of cases.  
5. Aphasia was associated with 28.5% of cases with right sided weakness   
vs 9% of cases with left sided weakness.
6. Association of  seizures  with neurological  outcome is  not  statistically   
significant (p=0.508). Among the patients who had seizures, 68% had 
poor residual motor weakness whereas 60% of cases who were seizure 
free had residual weakness.
7. Association  of  altered  level  of  consciousness  with  poor  neurological   
outcome is statistically not significant (p=0.195). 85.3% of cases who 
were drowsy at the onset and 80% of cases who were unconscious at the 
onset had residual weakness whereas 55% of patients who were alert at 
the onset had residual weakness.
8. Association  of  severity  of  neurological  deficit  with  neurological   
outcome is  statistically  significant  (p=0.031).  67.4% of  patients  with 
moderate  weakness  and  88.5%  of  cases  with  severe  weakness  had 
residual weakness whereas only 35.7% of cases with mild weakness had 
residual weakness.
9. MRI was  abnormal  in  all  patients  (infarct  in  83.8%,  hemorrhage  in   
10.3% and space occupying lesion in 5.9%).
10. The observation of the etiology of hemiplegia revealed that 7  6  9  .4% of   
cases  were  ischemic  stroke,  107.3%  were  hemorrhagic  stroke,  5.8% 
were  due  to  space  occupying  lesions,  5.8%  were  due  to  infective 
etiology and 1.7% was due to metabolic cause.
11. The observation of the etiology of  ischemic stroke revealed that 20.4%   
of cases had underlying cardiac disorder, either congenital or acquired 
followed by prothrombotic factors identified in 18.5% of cases, vascular 
etiology in 14.8%, miscellaneous causes in 14.7%, multiple risk factors 
in 20.4% and cause unknown in 11.2%.
12. Underlying cardiac disorder, either congenital or acquired was observed   
in  16% of  cases  and was  the  most  common risk  factor  followed by 
prothrombotic factors in 14.7%, which was statistically significant (chi-
square test - p=0.036).
13. The observation of the etiology of hemorrhagic stroke revealed that 60%   
of hemorrhagic stroke were due to blood dyscrasias and in 40% of cases, 
cause could not be identified.
14. Because of the high prevalence    and importance of multiple risk factors,   
complete  investigation,  including hematologic  al   and  metabolic  studies  
and  angiography,  should  be  considered  in  every  child  with  ischemic   
stroke, even  when a cause is known.  
CONCLUSION
              From this study it is concluded that ischemic stroke is 
more common than hemorrhagic stroke in children between 2 months 
and  12  years.  The  most  common  cause  of  ischemic  stroke  is 
cardiovascular  and  that  of  hemorrhagic  stroke  is  blood  dyscrasias. 
Seizures  and  altered  level  of  consciousness  were not  significantly 
associated  with  poor  neurological  outcome,  whereas  the  severity  of 
motor  weakness  at  the  onset  is  associated  with  poor  neurological 
outcome. Presence  of  multiple  risk  factors  is  associated  with  poor 
neurological outcome. Because of the high prevalence  and importance   
of multiple risk factors, a complete investigation,  including hematologic  al   
and metabolic studies and angiography,  should be considered in every   
child  with  ischemic  stroke,  even  when  a  cause  is  known.   Similarly,   
hemorrhagic stroke is associated with poor neurological outcome. There 
are no proven or widely accepted strategies for acute management or 
diagnostic  evaluation  of  intra parenchymal  hemorrhage  in  childhood, 
and  limited  data  exist  on  the  risks  vs  benefits  of  existing  treatment 
approaches.  There is  a paucity  of  literature to guide physicians who 
care for children with hemorrhagic stroke. Additional work is required in 
hemorrhagic,  as  well  as  arterial  ischemic  stroke  in  childhood. 
Randomized controlled trials of intervention will be essential. 
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                                                              PROFORMA
Name
Age
Sex
Unit 
IP NO
Date of admission and discharge
Presenting complaints
Sudden weakness of one side of body
Onset 
Type
Duration
Side of lesion
Speech
Vision 
Seizures
Fever 
Severe headache and vomiting
Loss of consciousness
Past history 
Family history
Bleeding disorder or 
Young stroke (in parents, uncle and grand parents)
General examination
Neurological examination
Investigations 
                  I .  F  or all patients  
CSF analysis 
Imaging : MRI scan
               I I. For patients presenting with infarct i  n  typical vascular distribution:  
 Cardiac evaluation 
             ECG
             Echocardiogram
             Carotid doppler
Blood tests 
              Complete blood count
              Erythrocyte sedimentation rate
              Protein C
              Protein S
              Antiphospholipid antibodies 
              Serum homocysteine
              Lipid profile              
                         III.   For patients presenting with infarct  with  non vascular   
distribution   
Serum lactate & pyruvate
                         I V  . For patients with hemorrhage  
Platelet count
Coagulation study
Bleeding time
Clotting time
Prothrombin time
APTT
Final diagnosis 
Treatment 
Follow up : periodically every 3 months for 1-2 years
            
ANNEXURE - I
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ANNEXURE – II
PROFORMA
1. Name :
2. I.P.No.:
3. Unit :
4. Date of admission:
5. Date of Discharge:
6. Age in months:
7. Sex: 1. Male
2. Female
8. Address:
9. Phone No.
10. Area: 1. Urban
2. Rural
11. Maternal Education 1. Illiterate
2. Primary Schooling
3. Secondary schooling
4. Graduation
12. Father's Occupation:1. Cooly
2. Clerical Job/Teacher
3. Self-employed
4. High Class
PRESENTING COMPLAINTS:
13. Motor Weakness: 1. One side weakness
2. One side weakness following seizures
3. Starts with loss of consciousness
4. Transient ischemic attacks
5. Evolving weakness
Figure : 1 Arterial Supply of Brain
Figure : 2 Motor Homonculus

Figure : 4 Ischemic penumbra
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Picture 5 : OUTCOME WITH RELATION TO THE SEVERITY OF 
WEAKNESS AT ONSET
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Picture  6 : OUTCOME OF ISCHEMIC VS HEMORRHAGIC INFARCT
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